var title_f39_43_40624="NSCLC adrenal met PETCT";
var content_f39_43_40624=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Adrenal metastasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 290px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    PET-CT showing intense metabolic activity in the right adrenal gland in a 76-year-old with a right paratracheal mass. CT guided adrenal biopsy confirmed stage IV non-small cell carcinoma of the lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40624=[""].join("\n");
var outline_f39_43_40624=null;
var title_f39_43_40625="Division of the left gastric vessels";
var content_f39_43_40625=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F81369&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F81369&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 556px\">",
"   <div class=\"ttl\">",
"    Division of the left gastric vessels",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 536px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The dissection is carried cephalad along the lesser curve of the stomach by dividing the gastrohepatic ligament towards the diaphragm. The left gastric vessels are identified and divided.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40625=[""].join("\n");
var outline_f39_43_40625=null;
var title_f39_43_40626="Pulmonary vein invasion";
var content_f39_43_40626=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58664&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58664&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary vein invasion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The axial CT scan shows a right lower lobe bronchogenic carcinoma invading the right inferior pulmonary vein, with extension into the left atrium. Transseptal invasion of the right atrium ensued.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40626=[""].join("\n");
var outline_f39_43_40626=null;
var title_f39_43_40627="Wrights stain P marneffei";
var content_f39_43_40627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Wright's-stained skin touch smear showing elongated yeast-like organisms with clear central septum, a typical characteristic of",
"    <em>",
"     Penicillium marneffei",
"    </em>",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drs. Khuanchai Supparatpinyo and Thira Sirisanthana.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40627=[""].join("\n");
var outline_f39_43_40627=null;
var title_f39_43_40628="Etoposide phosphate: Patient drug information";
var content_f39_43_40628=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Etoposide phosphate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/8/15495?source=see_link\">",
"     see \"Etoposide phosphate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F169380\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Etopophos&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may have unsafe effects on the bone marrow. The bone marrow may not be able to make cells found in the blood as well as it used to for a few weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4090502",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may irritate the vein. It may burn the skin if the drug leaks from the vein when it is given. Tell your nurse if you have any redness, burning, pain, swelling, or leaking of fluid where the drug is going into your body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027153\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702092",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to etoposide, etoposide phosphate, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697022",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use birth control that you can trust.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698261",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698237",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth and lip irritation. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698182",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation or swelling where the shot was given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698176",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       May not be able to get pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027156\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12209 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-84F2B57B49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40628=[""].join("\n");
var outline_f39_43_40628=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169380\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027152\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027154\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027153\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027158\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027159\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027161\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027156\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027163\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?15/8/15495?source=related_link\">",
"      Etoposide phosphate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_43_40629="Vertebral and spinal column";
var content_f39_43_40629=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F50257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F50257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Longitudinal organization of spinal cord, spinal nerves, and vertebrae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 439px; height: 618px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40629=[""].join("\n");
var outline_f39_43_40629=null;
var title_f39_43_40630="Idarubicin: Drug information";
var content_f39_43_40630=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Idarubicin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/40/29317?source=see_link\">",
"    see \"Idarubicin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/57/33685?source=see_link\">",
"    see \"Idarubicin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F181682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Idamycin PFS&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F181683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Idamycin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F181728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antineoplastic Agent, Anthracycline;",
"     </li>",
"     <li>",
"      Antineoplastic Agent, Antibiotic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F181686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual protocols.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      AML:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Induction:",
"     </i>",
"     12 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day for 3 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Consolidation:",
"     </i>",
"     10-12 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day for 2 days",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F181707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/57/33685?source=see_link\">",
"      see \"Idarubicin: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      AML (unlabeled use):",
"     </b>",
"     I.V.: 10-12 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     once daily for 3 days every 3 weeks.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F181687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F181688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     The FDA-approved labeling does not contain specific dosing adjustment guidelines; however, it does reccomend that dosage reductions be made. Patients with S",
"     <sub>",
"      cr",
"     </sub>",
"     : &ge;2 mg/dL did not receive treatment in many clinical trials. The following guidelines have been used by some clinicians (Aronoff, 2007):",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;50 mL/minute: Administer 75% of dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hemodialysis: Administer 75% of dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Continuous ambulatory peritoneal dialysis (CAPD): Administer 75% of dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT): Administer 75% of dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-50 mL/minute: Administer 75% of dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: Administer 50% of dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hemodialysis: Supplemental dose not needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Continuous ambulatory peritoneal dialysis (CAPD): Supplemental dose not needed.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F181689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bilirubin 2.6-5 mg/dL: Administer 50% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bilirubin &gt;5 mg/dL: Avoid use",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F181660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [preservative free]: 1 mg/mL (5 mL, 10 mL, 20 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Idamycin PFS&reg;: 1 mg/mL (5 mL, 10 mL, 20 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F181645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F181664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not administer I.M. or SubQ; administer as slow push over 3-5 minutes, preferably into the side of a freely-running saline or dextrose infusion",
"     <b>",
"      or",
"     </b>",
"     as intermittent infusion over 10-15 minutes into a free-flowing I.V. solution of NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W; also occasionally administered as a bladder lavage.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Extravasation management:",
"     </b>",
"     Topical cooling may be achieved using ice packs or cooling pad with circulating ice water. Cooling of site for 24 hours as tolerated by the patient. Elevate and rest extremity 24-48 hours, then resume normal activity as tolerated. Application of cold inhibits vesicant's cytotoxicity.",
"     <b>",
"      Application of heat can be harmful and is contraindicated.",
"     </b>",
"     If pain, erythema, and/or swelling persist beyond 48 hours, refer patient immediately to plastic surgeon for consultation and possible debridement.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F181734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR, NS, sterile water for injection,",
"     <b>",
"      incompatible",
"     </b>",
"     with bacteriostatic water.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amifostine, amikacin, aztreonam, cimetidine, cladribine, cyclophosphamide, cytarabine, diphenhydramine, droperidol, erythromycin lactobionate, etoposide phosphate, filgrastim, gemcitabine, granisetron, magnesium sulfate, mannitol, melphalan, metoclopramide, potassium chloride, ranitidine, sargramostim, thiotepa, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Acyclovir, allopurinol, ampicillin/sulbactam, cefazolin, cefepime, ceftazidime, clindamycin, dexamethasone sodium phosphate, etoposide, fluorouracil, furosemide, gentamicin, heparin, hydrocortisone sodium succinate, lorazepam, meperidine, methotrexate, piperacillin/tazobactam, sodium bicarbonate, teniposide, vancomycin, vincristine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Imipenem/cilastatin.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F181663\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of acute myeloid leukemia (AML)",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F181724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acute lymphocytic leukemia (ALL)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F181737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       IDArubicin may be confused with DOXOrubicin, DAUNOrubicin, epirubicin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Idamycin PFS&reg; may be confused with Adriamycin",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F181726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: CHF (dose related), transient ECG abnormalities (supraventricular tachycardia, S-T wave changes, atrial or ventricular extrasystoles); generally asymptomatic and self-limiting. The relative cardiotoxicity of idarubicin compared to doxorubicin is unclear. Some investigators report no increase in cardiac toxicity for adults at cumulative oral idarubicin doses up to 540 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     ; other reports suggest a maximum cumulative intravenous dose of 150 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Alopecia (25% to 30%), radiation recall, skin rash (11%), urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting (30% to 60%); diarrhea (9% to 22%); stomatitis (11%); GI hemorrhage (30%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Emetic potential: Moderate (30% to 60%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Discoloration of urine (darker yellow)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Myelosuppression (nadir: 10-15 days; recovery: 21-28 days), primarily leukopenia; thrombocytopenia and anemia. Effects are generally less severe with oral dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Bilirubin and transaminases increased (44%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Tissue necrosis upon extravasation, erythematous streaking",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Peripheral neuropathy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Cardiomyopathy, hyperuricemia, myocarditis, neutropenic typhlitis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F181667\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to idarubicin, other anthracyclines, or any component of the formulation; bilirubin &gt;5 mg/dL",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F181649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bone marrow suppression:",
"     <b>",
"      [U.S. Boxed Warning]: May cause severe myelosuppression.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperuricemia: Rapid lysis of leukemic cells may lead to hyperuricemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myocardial toxicity:",
"     <b>",
"      [U.S. Boxed Warning]: May cause myocardial toxicity (HF, arrhythmias or cardiomyopathies) and is more common in patients who have previously received anthracyclines or have pre-existing cardiac disease.",
"     </b>",
"     The risk of myocardial toxicity is also increased in patients with concomitant or prior mediastinal/pericardial irradiation, patients with anemia, bone marrow depression, infections, leukemic pericarditis or myocarditis. Monitor cardiac function during treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin irritation/extravasation:",
"     <b>",
"      [U.S. Boxed Warning]  For I.V. administration only; may cause severe local tissue damage and necrosis if extravasation occurs.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bone marrow suppression: Use with extreme caution in patients with pre-existing bone marrow suppression from prior treatment or radiation; use only if benefits warrants risks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with pre-existing cardiac disease; may increase risk of cardiotoxicity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment:",
"     <b>",
"      [U.S. Boxed Warning] Use with caution in patients with hepatic impairment; may require dosage reductions.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infections: Systemic infections should be managed prior to initiation of treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment:",
"     <b>",
"      [U.S. Boxed Warning] Use with caution in patients with renal impairment; may require dosage reductions.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Experienced physician:",
"     <b>",
"      [U.S. Boxed Warning]: Should be administered under the supervision of an experienced cancer chemotherapy physician.",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F9838176\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of P-glycoprotein",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F181654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bevacizumab: May enhance the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: May diminish the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic). Antineoplastic Agents (Anthracycline, Systemic) may decrease the serum concentration of Cardiac Glycosides. The effects of liposomal formulations may be unique from those of the free drug, as liposomal formulation have unique drug disposition and toxicity profiles, and liposomes themselves may alter digoxin absorption/distribution.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Taxane Derivatives: May enhance the adverse/toxic effect of Antineoplastic Agents (Anthracycline, Systemic). Taxane Derivatives may increase the serum concentration of Antineoplastic Agents (Anthracycline, Systemic). Taxane Derivatives may also increase the formation of toxic anthracycline metabolites in heart tissue.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F181656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14206274\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in animal studies. Fetal fatality was noted in a case report following use in a pregnant woman during the second trimester. The manufacturer recommends that women of childbearing potential avoid pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F181695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Idamycin PFS Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg/5 mL (5 mL): $300.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/10 mL (10 mL): $600.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg/20 mL (20 mL): $1200.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (IDArubicin HCl Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg/5 mL (5 mL): $92.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/10 mL (10 mL): $197.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg/20 mL (20 mL): $395.28",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F181658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential, platelet count, cardiac function, serum electrolytes, creatinine, uric acid, ALT, AST, bilirubin, signs of extravasation",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F181670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Idamycin (MX);",
"     </li>",
"     <li>",
"      Idaralem (TH);",
"     </li>",
"     <li>",
"      Zavedos (AE, AR, AT, AU, BE, BG, BH, BR, CH, CL, CN, CO, CY, CZ, DE, DK, EC, EE, EG, ES, FI, FR, GB, GR, HK, HN, HR, HU, IE, IL, IN, IQ, IR, IT, JO, KP, KW, LB, LU, LY, MT, MY, NL, NO, NZ, OM, PE, PH, PK, PL, PT, QA, RU, SA, SE, SK, SY, TH, TR, TW, UY, VE, YE, ZA);",
"     </li>",
"     <li>",
"      Zavedos CS (SG)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F181648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Similar to doxorubicin and daunorubicin; inhibition of DNA and RNA synthesis by intercalation between DNA base pairs",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F181666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Variable (4% to 77%; mean: ~30%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 64 L/kg (some reports indicate 2250 L); extensive tissue binding; CSF",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 94% to 97%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic to idarubicinol (pharmacologically active)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Oral: 14-35 hours; I.V.: 12-27 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 1-5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Urine (~5% of dose; 0.5% to 0.7% as unchanged drug, 4% as idarubicinol); hepatic (8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Urine (13% as idarubicinol, 3% as unchanged drug); hepatic (17%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Arlin ZA, &ldquo;Idarubicin in Acute Leukemia: An Effective New Therapy for the Future,&rdquo;",
"      <i>",
"       Semin Oncol",
"      </i>",
"      , 1989, 16(1 Suppl 2):35-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/2648582/pubmed\" id=\"2648582\" target=\"_blank\">",
"        2648582",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 100, 172.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Berman E, &ldquo;A Review of Idarubicin in Acute Leukemia,&rdquo;",
"      <i>",
"       Oncology",
"      </i>",
"      , 1993, 7(10):91-8, 104.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/8251309/pubmed\" id=\"8251309\" target=\"_blank\">",
"        8251309",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Blijlevens NM, Donnelly JP, and de Pauw BE, \"Prospective Evaluation of Gut Mucosal Barrier Injury Following Various Myeloablative Regimens for Haematopoietic Stem Cell Transplant,\"",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 2005, 35:707-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/15785771/pubmed\" id=\"15785771\" target=\"_blank\">",
"        15785771",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Borchmann P, Hubel K, Schnell R, et al, &ldquo;Idarubicin: A Brief Overview on Pharmacology and Clinical Use,&rdquo;",
"      <i>",
"       Int J Clin Pharmacol Ther",
"      </i>",
"      , 1997, 35(2):80-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/9147715/pubmed\" id=\"9147715\" target=\"_blank\">",
"        9147715",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Buckley MM and Lamb HM, \"Oral Idarubicin. A Review of its Pharmacological Properties and Clinical Efficacy in the Treatment of Haematological Malignancies and Advanced Breast Cancer,\"",
"      <i>",
"       Drugs Aging",
"      </i>",
"      , 1997, 11(1):61-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/9237041/pubmed\" id=\"9237041\" target=\"_blank\">",
"        9237041",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ferrara F, Palmieri S, Annunziata M, et al, &ldquo;Continuous Infusion Idarubicin and Oral Busulfan as Conditioning for Patients With Acute Myeloid Leukemia Aged Over 60 Years Undergoing Autologous Stem Cell Transplantation,&rdquo;",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 2004, 34(7):73-576.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fields SM and Koeller JM, &ldquo;Idarubicin: A Second Generation Anthracycline,&rdquo;",
"      <i>",
"       DICP",
"      </i>",
"      , 1991, 25(5):505-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/2068836/pubmed\" id=\"2068836\" target=\"_blank\">",
"        2068836",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Floyd JD, Nguyen DT, Lobins RL, et al, &ldquo;Cardiotoxicity of Cancer Therapy,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2005, 23(30):7685-96.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/16234530/pubmed\" id=\"16234530\" target=\"_blank\">",
"        16234530",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goebel M, \"Oral Idarubicin--An Anthracycline Derivative With Unique Properties,\"",
"      <i>",
"       Ann Hematol",
"      </i>",
"      , 1993, 66(1):33-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/8431520/pubmed\" id=\"8431520\" target=\"_blank\">",
"        8431520",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hollingshead LM and Faulds D, &ldquo;Idarubicin: A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in the Chemotherapy of Cancer,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1991, 42(4):690-719.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/1723369/pubmed\" id=\"1723369\" target=\"_blank\">",
"        1723369",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mengarelli A, Iori AP, Guglielmi C, et al, \"Idarubicin Intensified BUCY2 Regimen in Allogeneic Unmanipulated Transplant for High-Risk Hematological Malignancies,\"",
"      <i>",
"       Leukemia",
"      </i>",
"      , 2000, 14(12):2052-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/11187892/pubmed\" id=\"11187892\" target=\"_blank\">",
"        11187892",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Morgan C, Tillett T, Braybrooke J, et al, &ldquo;Management of Uncommon Chemotherapy-Induced Emergencies,&rdquo;",
"      <i>",
"       Lancet Oncol",
"      </i>",
"      , 2011, 12(8):806-14.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/21276754/pubmed\" id=\"21276754\" target=\"_blank\">",
"        21276754",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Robert J, \"Clinical Pharmacokinetics of Edarubicin,\"",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1993, 24(4):275-88.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/43/40630/abstract-text/8491056/pubmed\" id=\"8491056\" target=\"_blank\">",
"        8491056",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8549 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-218.28.111.102-E73EFF4BA8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40630=[""].join("\n");
var outline_f39_43_40630=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708916\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181682\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181683\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181728\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181686\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181707\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181687\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181688\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181689\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181660\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181645\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181664\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181734\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181663\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181724\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181737\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181726\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181667\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181649\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9838176\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181654\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181656\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14206274\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181695\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323191\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181658\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181670\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181648\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181666\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8549\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8549|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/40/29317?source=related_link\">",
"      Idarubicin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/57/33685?source=related_link\">",
"      Idarubicin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_43_40631="Spinal cord infarction: Vascular anatomy and etiologies";
var content_f39_43_40631=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Spinal cord infarction: Vascular anatomy and etiologies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/43/40631/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40631/contributors\">",
"     Michael Mullen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40631/contributors\">",
"     Michael L McGarvey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/43/40631/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40631/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/43/40631/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40631/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/43/40631/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal cord infarction is a rare but often devastating disorder caused by a wide array of pathologic states. Patients typically present with acute paraparesis or quadriparesis, depending on the level of the spinal cord involved. The diagnosis is generally made clinically, with neuroimaging to confirm the diagnosis and exclude other conditions.",
"   </p>",
"   <p>",
"    This topic discusses the vascular anatomy of the spinal cord as well as the epidemiology and causes of spinal cord infarction. The clinical features, diagnosis, prognosis, treatment and chronic complications of spinal cord infarction are discussed separately. Other causes of myelopathy are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30230?source=see_link\">",
"     \"Spinal cord infarction: Clinical presentation and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23333?source=see_link\">",
"     \"Spinal cord infarction: Prognosis and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37642?source=see_link\">",
"     \"Chronic complications of spinal cord injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/42/32426?source=see_link\">",
"     \"Disorders affecting the spinal cord\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/44/5832?source=see_link\">",
"     \"Anatomy and localization of spinal cord disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of spinal cord infarction has not been specifically reported. It has been estimated that spinal cord infarction accounts for approximately 1 percent of all strokes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Extrapolating from estimates of total stroke incidence in the United States, which range from 540,000 to 780,000 per year, it is expected that 5000 to 8000 cases of spontaneous spinal cord infarction occur per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. This may be an underestimate, as these figures likely do not include spinal cord infarction complicating major surgery, which is the most common cause of spinal cord infarction.",
"   </p>",
"   <p>",
"    Spinal cord infarction typically occurs in adults; this is expected as it is usually a direct or indirect complication of atherosclerotic vascular disease; in one series, the mean age was 64 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/5\">",
"     5",
"    </a>",
"    ]. However, children, even neonates, can develop spinal cord infarction in specific circumstances (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Etiologies'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     VASCULAR ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three major vessels arising from the vertebral arteries in the neck supply the spinal cord (",
"    <a class=\"graphic graphic_figure graphicRef62845 \" href=\"mobipreview.htm?8/49/8980\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/6\">",
"     6",
"    </a>",
"    ]. There is one anterior spinal artery (ASA) and a pair of posterior spinal arteries (PSA). The ASA supplies the anterior two-thirds of the spinal cord. The ASA and PSAs anastomose distally at the conus medullaris [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Anterior spinal artery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ASA arises from the vertebral arteries at the level of the foramen magnum. It runs along the center of the anterior aspect of the spinal cord in the anterior median sulcus from the foramen magnum to the conus medullaris, making it the longest artery in the body [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/7\">",
"     7",
"    </a>",
"    ]. Although it is typically continuous throughout its course, the diameter of the ASA varies considerably throughout its length [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/8\">",
"     8",
"    </a>",
"    ]. It is smallest in the thoracic segment and largest in the lumbosacral region [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Along its course, the ASA is augmented by radicular arteries. These small arteries enter the spinal canal though the intervertebral foramen and supply blood to the emerging nerve roots. They originate from the vertebral arteries, intercostal arteries, or in rare instances, directly from the aorta. Typically just 6 to 10 of the 31 pairs of radicular arteries (one pair at each spinal level) contribute to the ASA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/10\">",
"     10",
"    </a>",
"    ]. These arteries usually enter the spinal canal from the left neural foramen, but may be bilateral, particularly in the cervical spine. The thoracic spinal cord is particularly dependent on radicular contributions and may be the most vulnerable to infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The most prominent thoracic radicular artery is the artery of Adamkiewicz, also known as the artery of the lumbar enlargement. The artery of Adamkiewicz contributes to the ASA between the T9 to T12 level in 75 percent of individuals, but may be found above and below this level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    From the ASA, sulcal arteries run into the center of the cord and then branch to the right or the left to supply the deep structures of the spinal cord. The ASA also contributes to a peripheral arterial plexus, which gives off radial branches to supply the periphery of the cord. The ASA supplies blood to the anterior horns of the gray matter, spinothalamic tracts, and corticospinal tracts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Posterior spinal artery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The PSAs originate from the vertebral arteries and travel the length of the cord in the posterior lateral sulci bilaterally. The PSAs vary greatly in diameter throughout their course and may even be discontinuous. The PSAs are supported by a greater number of radicular arteries than the ASA, commonly between 10 and 23 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/10\">",
"     10",
"    </a>",
"    ]. These radicular arteries typically originate from the left but are more frequently bilateral than those contributing to the ASA. The PSAs frequently anastomose with each other, and are heavily connected to the peripheral and posterolateral plexuses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/7,9\">",
"     7,9",
"    </a>",
"    ]. The PSAs supply the dorsal columns and the posterior horns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Venous system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two major spinal veins, one anterior and one posterior, drain into a series of radicular veins, then into intravertebral and paravertebral plexuses, and finally into the azygous and pelvic venous systems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/11\">",
"     11",
"    </a>",
"    ]. Because spinal veins contain no valves, Valsalva and increased intra-abdominal pressure can lead to increased venous pressure and decreased spinal cord perfusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Factors that modulate blood flow",
"    </span>",
"    &nbsp;&mdash;&nbsp;As in the brain, spinal blood flow is influenced by metabolic demand and responds to both hypoxia and hypercapnia with increased blood flow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/11\">",
"     11",
"    </a>",
"    ]. Metabolic demand and blood flow is highest in the gray matter, which is most abundant in the cervical and lumbar enlargements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood flow to the spinal cord is also influenced by perfusion pressure, which is the difference between mean arterial and intraspinal canal pressure. Through autoregulation, spinal blood flow is maintained at a constant level over a range of mean arterial pressures. However, there are lower and upper limits of systemic blood pressure beyond which autoregulation fails [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/12,14\">",
"     12,14",
"    </a>",
"    ]. As a result, systemic hypotension or increased intraspinal canal pressure may decrease perfusion and put the cord at risk. Because the spinal cord exists in a fixed space, intraspinal canal pressure is sensitive to changes in the contents of the spinal canal and may rise significantly in pathologic states.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A broad spectrum of diseases can cause spinal cord infarction (",
"    <a class=\"graphic graphic_table graphicRef57862 \" href=\"mobipreview.htm?5/36/5709\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/9\">",
"     9",
"    </a>",
"    ]. The mechanisms underlying these can be broadly categorized:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diseases or procedures involving the thoracoabdominal aorta",
"     </li>",
"     <li>",
"      Intrinsic arterial occlusion resulting from arteriosclerosis, vasculitis, infection, embolic occlusion, thrombosis",
"     </li>",
"     <li>",
"      Hypoperfusion",
"     </li>",
"     <li>",
"      Venous infarction",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Aortic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery to repair thoracic and thoracoabdominal aortic aneurysms is the most common cause of spinal cord infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/1,5,9,11,15-17\">",
"     1,5,9,11,15-17",
"    </a>",
"    ]. Rates of spinal cord ischemia following thoracic aortic surgery have been reported to be as high as 29 percent, but are more usually reported as 10 to 11 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/18\">",
"     18",
"    </a>",
"    ]. Both open surgery and endovascular repair are associated with spinal cord ischemia. Risks appear to be somewhat lower with an endovascular approach, but selection bias of patients for this procedure may play a role in this finding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spinal cord ischemia after thoracic aortic surgery may be clinically apparent immediately after surgery, or after a period of normal neurologic functioning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/20\">",
"     20",
"    </a>",
"    ]. Delayed spinal cord ischemia has been reported as late as 27 days after surgical repair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many factors may play a role in this complication. These include systemic hypotension, before, during, or after the procedure; aortic cross clamping causing decreased arterial perfusion and increased spinal canal pressure; and occlusion of important feeding arteries such as the artery of Adamkiewicz or other intercostal arteries either by ligation, resection, or embolization. Episodes of systemic hypotension in many cases appear to be temporally associated with delayed onset of ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for spinal cord ischemia following aneurysm repair have been reported to include advanced age, aortic rupture, history of cerebrovascular disease, prior aortic surgery, more extensive aortic disease (eg, Crawford",
"    <span class=\"nowrap\">",
"     II/III",
"    </span>",
"    repairs), postoperative bleeding, long cross clamp duration, intraoperative hypotension, sacrifice of intercostal vessels, renal insufficiency, and atrial fibrillation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/18,21-23\">",
"     18,21-23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Efforts to reduce the risk of spinal cord ischemia have included placement of lumbar drains, reimplantation of intercostal arteries, intraoperative neurophysiologic monitoring, epidural cooling, use of distal aortic perfusion, and arterial blood pressure augmentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/15,18,20,22-26\">",
"     15,18,20,22-26",
"    </a>",
"    ]. While these interventions appear to improve outcomes, these have not been studied in a randomized or carefully controlled fashion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Aortic dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute dissection of the descending aorta is often a catastrophic event and is associated with a high mortality (10 to 50 percent). Survivors of the acute event often contend with complications resulting from acute occlusion of branch vessels that include celiac, superior mesenteric, and renal arteries, as well as radicular arterial supply to the spinal cord. The incidence of spinal cord infarction with aortic dissection is reported to be 4 percent; spinal cord ischemia as the presenting symptom of aortic dissection is more unusual, but has been described in a number of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/27-31\">",
"     27-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Typically, spinal cord infarction in this setting involves the mid and lower thoracic cord levels. Severe \"tearing\" pain and abnormal distal pulses suggest this diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/28,32\">",
"     28,32",
"    </a>",
"    ]. However, 5 to 15 percent of acute aortic dissections are painless, requiring a high degree of suspicion for this diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/29,30,33\">",
"     29,30,33",
"    </a>",
"    ]. Chronic hypertension, underlying atherosclerotic vascular disease and Marfan syndrome are among the risk factors for aortic dissection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/19/25914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of aortic dissection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other aortic pathologies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal cord infarction can complicate traumatic aortic rupture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/11\">",
"     11",
"    </a>",
"    ]. Other pathologies involving the descending aorta, such as aneurysm formation and thrombosis, have also been presumed to be causative in some patients with acute spinal cord infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/11,16,35-37\">",
"     11,16,35-37",
"    </a>",
"    ]. Coarctation of the aorta and its corrective surgery is a less common cause of spinal cord infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/38\">",
"     38",
"    </a>",
"    ]. Spinal cord infarction can also complicate aortography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Nonaortic surgeries",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other surgical procedures are associated with spinal cord ischemia, of these, spine surgery is the most common, however, bowel resection, hepatectomy, caesarean section, hip and prostate surgery, and many other procedures have also been associated with spinal cord infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/5,9,11,16,40,41\">",
"     5,9,11,16,40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical injury to a radicular feeding artery probably plays a role in many of these cases. Others have wondered about the role of epidural anesthesia possibly causing direct injury to an artery or inducing vasospasm in some cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/35,41\">",
"     35,41",
"    </a>",
"    ]. In some patients, intra- or peri-operative hypotension appeared to be contributory. Others have noted that many patients with perioperative spinal cord infarction have underlying aortic disease",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    prior aortic surgery, perhaps increasing their susceptibility to this complication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Fibrocartilaginous embolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibrocartilaginous embolism (FCE) is a rare phenomenon that can cause spinal cord infarction. FCE originates from herniated intervertebral discs. A temporal relationship to minor head or neck injury or heavy lifting is a clue to this etiology, but is not always present. A broad age range of patients (7 to 78 years) can be affected by this phenomenon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. Most cases involve the cervical cord; some involve the lower medulla or upper thoracic cord. Neck pain typically precedes neurologic symptoms by 15 minutes to 48 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/42,44-47\">",
"     42,44-47",
"    </a>",
"    ]. MRI may show a collapsed intervertebral disc at the appropriate level. Because the upper cervical cord is involved, case-fatality rates appear to be relatively high.",
"   </p>",
"   <p>",
"    The pathogenesis of this phenomenon is uncertain. It is hypothesized that axial loading forces on the spinal column produce a high intra-disc pressure causing the injection of semifluid disc material into the disc vasculature",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to the bone marrow and venous sinuses of the vertebral bodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/44\">",
"     44",
"    </a>",
"    ]. This material may then spread retrograde to involve blood vessels supplying the spinal cord. Autopsy typically reveals fibrocartilaginous material occluding local arteries",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    veins. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/44,48,49\">",
"     44,48,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Systemic hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spinal cord is vulnerable to ischemic injury during episodes of systemic hypotension (eg, cardiopulmonary arrest, systemic bleeding, etc). One autopsy series found evidence of ischemic myelopathy in 46 percent of adults who died after a cardiac arrest or severe hypotensive episode [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/50\">",
"     50",
"    </a>",
"    ]. The predominant level of involvement was the lumbosacral cord. This phenomenon is also described in neonates, particularly premature neonates, after episodes of hypotension in the perinatal period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/51\">",
"     51",
"    </a>",
"    ]. Among survivors, ischemic myelopathy can be obscured by hypoxic ischemic encephalopathy; however, in a number of cases, spinal cord infarction is the principal complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/11,35,52\">",
"     11,35,52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Vascular malformation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common presentation of a spinal vascular malformation is that of a progressive, step-wise myelopathy. However, some patients may have a more abrupt or stroke-like presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/42/32426?source=see_link&amp;anchor=H17#H17\">",
"     \"Disorders affecting the spinal cord\", section on 'Vascular malformations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among case series, between 44 to 74 percent of patients with spinal cord infarction do not have an identified etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/1,5,16,35,36,53-57\">",
"     1,5,16,35,36,53-57",
"    </a>",
"    ]. In many of these cases, atherosclerotic risk factors are prevalent, and atherothrombotic disease is presumed to be responsible for at least some of these cases. However, this pathology has not been specifically described. Moreover, a small percentage of patients in many series include patients with no identifiable etiology and no vascular risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other causes of spinal cord infarction are numerous (",
"    <a class=\"graphic graphic_table graphicRef57862 \" href=\"mobipreview.htm?5/36/5709\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/9\">",
"     9",
"    </a>",
"    ]. A few of the more common of these rare conditions include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vasculitis resulting from bacterial or syphilitic infection, systemic lupus erythematosus, and polyarteritis nodosa which can be a cause of spinal cord infarction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/1,11,53,54,58\">",
"       1,11,53,54,58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Vertebral artery atheroma and dissection which has been associated with rostral cervical cord infarction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/16,36,59\">",
"       16,36,59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Both inherited and acquired hypercoagulable conditions as well as sickle cell disease which appear to underlie some cases of spinal cord infarction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/11,60-63\">",
"       11,60-63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cervical spondylosis which has been postulated to be a cause of spinal cord infarction, perhaps by causing dissection or compression of a radicular artery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/11,35,64\">",
"       11,35,64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Umbilical artery catheters used in newborns which can rarely cause occlusion of the artery of Adamkiewicz, resulting in spinal cord infarction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/65,66\">",
"       65,66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cocaine-related arteropathy which has been thought to cause spinal cord infarction in a few patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Emboli from a variety of cardiogenic sources (artificial valves, vegetations) which have also been implicated as the cause of spinal cord infarction in a number of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40631/abstract/16,35,53,67-69\">",
"       16,35,53,67-69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Decompression sickness myelopathy which may have a vascular pathogenesis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/42/32426?source=see_link&amp;anchor=H24#H24\">",
"       \"Disorders affecting the spinal cord\", section on 'Decompression sickness myelopathy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal cord infarction is a rare condition caused by a wide array of pathologic conditions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common cause of spinal cord infarction is surgical repair of the thoracoabdominal aorta. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Aortic surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Spinal cord ischemia can also result from other pathologies involving the aorta, including aortic dissection. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Aortic dissection'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Other aortic pathologies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Spinal cord infarction can also complicate other nonaortic surgeries, as well as episodes of profound systemic hypotension such as those occurring during cardiopulmonary arrest. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Nonaortic surgeries'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Systemic hypotension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other causes of spinal cord infarction are diverse (",
"      <a class=\"graphic graphic_table graphicRef57862 \" href=\"mobipreview.htm?5/36/5709\">",
"       table 1",
"      </a>",
"      ). A large proportion of spontaneous spinal cord infarction do not have an identified etiology; many of these are presumably secondary to atherothrombotic disease. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Other causes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/1\">",
"      Sandson TA, Friedman JH. Spinal cord infarction. Report of 8 cases and review of the literature. Medicine (Baltimore) 1989; 68:282.",
"     </a>",
"    </li>",
"    <li>",
"     Geldmacher DS, Bowen BC. Vascular Disease of the Nervous System. In: Neurology in Clinical Practice, 4th, Bradley WG, Daroff RB, Fenichel GM, Jankovic J (Eds), Butterworth Heinemann, Philadelphia 2004. p.1313.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/3\">",
"      Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the \"common\" neurologic disorders? Neurology 2007; 68:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/4\">",
"      Williams GR. Incidence and characteristics of total stroke in the United States. BMC Neurol 2001; 1:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/5\">",
"      Robertson CE, Brown RD Jr, Wijdicks EF, Rabinstein AA. Recovery after spinal cord infarcts: long-term outcome in 115 patients. Neurology 2012; 78:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/6\">",
"      Prasad S, Price RS, Kranick SM, et al. Clinical reasoning: a 59-year-old woman with acute paraplegia. Neurology 2007; 69:E41.",
"     </a>",
"    </li>",
"    <li>",
"     Hurst RW. Spinal vascular disorders. In: Resonance Imaging of the Brain and Spine, 2nd, Atlas SW (Ed), Lippincott, Philadelphia 2006. p.1387.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/8\">",
"      Biglioli P, Roberto M, Cannata A, et al. Upper and lower spinal cord blood supply: the continuity of the anterior spinal artery and the relevance of the lumbar arteries. J Thorac Cardiovasc Surg 2004; 127:1188.",
"     </a>",
"    </li>",
"    <li>",
"     Mohr JP, Benavente O, Barnett HJ. Spinal Cord Ischemia. In: Stroke Pathophysiology, Diagnosis, and Management, Barnett HJ, Mohr JP, Stein BM, Yatsu FM (Eds), Churchill Livingstone, Philadelphia 1998. p.423.",
"    </li>",
"    <li>",
"     Parent A. Blood Supply of the Central Nervous System. In: Carpenter's Human Neuroanatomy, 9th, Williams and Wilkins, 1996. p.93.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/11\">",
"      Cheshire WP, Santos CC, Massey EW, Howard JF Jr. Spinal cord infarction: etiology and outcome. Neurology 1996; 47:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/12\">",
"      Marcus ML, Heistad DD, Ehrhardt JC, Abboud FM. Regulation of total and regional spinal cord blood flow. Circ Res 1977; 41:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/13\">",
"      Sandler AN, Tator CH. Effect of acute spinal cord compression injury on regional spinal cord blood flow in primates. J Neurosurg 1976; 45:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/14\">",
"      Hickey R, Albin MS, Bunegin L, Gelineau J. Autoregulation of spinal cord blood flow: is the cord a microcosm of the brain? Stroke 1986; 17:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/15\">",
"      McGarvey ML, Cheung AT, Szeto W, Messe SR. Management of neurologic complications of thoracic aortic surgery. J Clin Neurophysiol 2007; 24:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/16\">",
"      Weidauer S, Nichtweiss M, Lanfermann H, Zanella FE. Spinal cord infarction: MR imaging and clinical features in 16 cases. Neuroradiology 2002; 44:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/17\">",
"      Iseli E, Cavigelli A, Dietz V, Curt A. Prognosis and recovery in ischaemic and traumatic spinal cord injury: clinical and electrophysiological evaluation. J Neurol Neurosurg Psychiatry 1999; 67:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/18\">",
"      Mess&eacute; SR, Bavaria JE, Mullen M, et al. Neurologic outcomes from high risk descending thoracic and thoracoabdominal aortic operations in the era of endovascular repair. Neurocrit Care 2008; 9:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/19\">",
"      Xenos ES, Abedi NN, Davenport DL, et al. Meta-analysis of endovascular vs open repair for traumatic descending thoracic aortic rupture. J Vasc Surg 2008; 48:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/20\">",
"      Cheung AT, Weiss SJ, McGarvey ML, et al. Interventions for reversing delayed-onset postoperative paraplegia after thoracic aortic reconstruction. Ann Thorac Surg 2002; 74:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/21\">",
"      Maniar HS, Sundt TM 3rd, Prasad SM, et al. Delayed paraplegia after thoracic and thoracoabdominal aneurysm repair: a continuing risk. Ann Thorac Surg 2003; 75:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/22\">",
"      Cambria RP, Clouse WD, Davison JK, et al. Thoracoabdominal aneurysm repair: results with 337 operations performed over a 15-year interval. Ann Surg 2002; 236:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/23\">",
"      Estrera AL, Miller CC 3rd, Huynh TT, et al. Neurologic outcome after thoracic and thoracoabdominal aortic aneurysm repair. Ann Thorac Surg 2001; 72:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/24\">",
"      Crawford ES, Mizrahi EM, Hess KR, et al. The impact of distal aortic perfusion and somatosensory evoked potential monitoring on prevention of paraplegia after aortic aneurysm operation. J Thorac Cardiovasc Surg 1988; 95:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/25\">",
"      Cheung AT, Pochettino A, McGarvey ML, et al. Strategies to manage paraplegia risk after endovascular stent repair of descending thoracic aortic aneurysms. Ann Thorac Surg 2005; 80:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/26\">",
"      Sloan TB, Jameson LC. Electrophysiologic monitoring during surgery to repair the thoraco-abdominal aorta. J Clin Neurophysiol 2007; 24:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/27\">",
"      Sandridge L, Kern JA. Acute descending aortic dissections: management of visceral, spinal cord, and extremity malperfusion. Semin Thorac Cardiovasc Surg 2005; 17:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/28\">",
"      Gaul C, Dietrich W, Friedrich I, et al. Neurological symptoms in type A aortic dissections. Stroke 2007; 38:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/29\">",
"      Joo JB, Cummings AJ. Acute thoracoabdominal aortic dissection presenting as painless, transient paralysis of the lower extremities: a case report. J Emerg Med 2000; 19:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/30\">",
"      Donovan EM, Seidel GK, Cohen A. Painless aortic dissection presenting as high paraplegia: a case report. Arch Phys Med Rehabil 2000; 81:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/31\">",
"      Zull DN, Cydulka R. Acute paraplegia: a presenting manifestation of aortic dissection. Am J Med 1988; 84:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/32\">",
"      Nandeesh BN, Mahadevan A, Santosh V, et al. Acute aortic dissection presenting as painful paraplegia. Clin Neurol Neurosurg 2007; 109:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/33\">",
"      Inamasu J, Hori S, Yokoyama M, et al. Paraplegia caused by painless acute aortic dissection. Spinal Cord 2000; 38:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/34\">",
"      Wityk RJ, Zanferrari C, Oppenheimer S. Neurovascular complications of marfan syndrome: a retrospective, hospital-based study. Stroke 2002; 33:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/35\">",
"      Nedeltchev K, Loher TJ, Stepper F, et al. Long-term outcome of acute spinal cord ischemia syndrome. Stroke 2004; 35:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/36\">",
"      Masson C, Pruvo JP, Meder JF, et al. Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry 2004; 75:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/37\">",
"      Hussain MS, Shuaib A, Siddiqi ZA. Spinal cord transient ischemic attacks: a possible role for abciximab. Neurology 2005; 64:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/38\">",
"      Servais LJ, Rivelli SK, Dachy BA, et al. Anterior spinal artery syndrome after aortic surgery in a child. Pediatr Neurol 2001; 24:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/39\">",
"      Restrepo L, Guttin JF. Acute spinal cord ischemia during aortography treated with intravenous thrombolytic therapy. Tex Heart Inst J 2006; 33:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/40\">",
"      Winter RB. Neurologic safety in spinal deformity surgery. Spine (Phila Pa 1976) 1997; 22:1527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/41\">",
"      Hobai IA, Bittner EA, Grecu L. Perioperative spinal cord infarction in nonaortic surgery: report of three cases and review of the literature. J Clin Anesth 2008; 20:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/42\">",
"      Duprez TP, Danvoye L, Hernalsteen D, et al. Fibrocartilaginous embolization to the spinal cord: serial MR imaging monitoring and pathologic study. AJNR Am J Neuroradiol 2005; 26:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/43\">",
"      Beer S, Kesselring J. Fibrocartilaginous embolisation of the spinal cord in a 7-year-old girl. J Neurol 2002; 249:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/44\">",
"      Tosi L, Rigoli G, Beltramello A. Fibrocartilaginous embolism of the spinal cord: a clinical and pathogenetic reconsideration. J Neurol Neurosurg Psychiatry 1996; 60:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/45\">",
"      Heckmann JG, D&uuml;tsch M, Struffert T, et al. Spinal cord infarction: a case of fibrocartilaginous embolism? Eur J Neurol 2007; 14:e23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/46\">",
"      Th&ouml;ne J, Hohaus A, Bickel A, Erbguth F. Severe spinal cord ischemia subsequent to fibrocartilaginous embolism. J Neurol Sci 2007; 263:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/47\">",
"      Raghavan A, Onikul E, Ryan MM, et al. Anterior spinal cord infarction owing to possible fibrocartilaginous embolism. Pediatr Radiol 2004; 34:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/48\">",
"      Piao YS, Lu DH, Su YY, Yang XP. Anterior spinal cord infarction caused by fibrocartilaginous embolism. Neuropathology 2009; 29:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/49\">",
"      Freyaldenhoven TE, Mrak RE, Rock L. Fibrocartilaginous embolization. Neurology 2001; 56:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/50\">",
"      Duggal N, Lach B. Selective vulnerability of the lumbosacral spinal cord after cardiac arrest and hypotension. Stroke 2002; 33:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/51\">",
"      Sladky JT, Rorke LB. Perinatal hypoxic/ischemic spinal cord injury. Pediatr Pathol 1986; 6:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/52\">",
"      Lin CC, Chen SY, Lan C, et al. Spinal cord infarction caused by cardiac tamponade. Am J Phys Med Rehabil 2002; 81:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/53\">",
"      Novy J, Carruzzo A, Maeder P, Bogousslavsky J. Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol 2006; 63:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/54\">",
"      Salvador de la Barrera S, Barca-Buyo A, Montoto-Marqu&eacute;s A, et al. Spinal cord infarction: prognosis and recovery in a series of 36 patients. Spinal Cord 2001; 39:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/55\">",
"      Martinelli V, Comi G, Rovaris M, et al. Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short- and long-term prognostic factors. J Neurol 1995; 242:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/56\">",
"      Cheng MY, Lyu RK, Chang YJ, et al. Spinal cord infarction in Chinese patients. Clinical features, risk factors, imaging and prognosis. Cerebrovasc Dis 2008; 26:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/57\">",
"      Cheng MY, Lyu RK, Chang YJ, et al. Concomitant spinal cord and vertebral body infarction is highly associated with aortic pathology: a clinical and magnetic resonance imaging study. J Neurol 2009; 256:1418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/58\">",
"      Rathore MF, Gill ZA, Malik AA, Farooq F. Acute flaccid paraplegia: a rare complication of meningococcal meningitis. Spinal Cord 2008; 46:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/59\">",
"      Laufs H, Weidauer S, Heller C, et al. Hemi-spinal cord infarction due to vertebral artery dissection in congenital afibrinogenemia. Neurology 2004; 63:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/60\">",
"      Hakimi KN, Massagli TL. Anterior spinal artery syndrome in two children with genetic thrombotic disorders. J Spinal Cord Med 2005; 28:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/61\">",
"      Young G, Krohn KA, Packer RJ. Prothrombin G20210A mutation in a child with spinal cord infarction. J Pediatr 1999; 134:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/62\">",
"      Ramelli GP, Wyttenbach R, von der Weid N, Ozdoba C. Anterior spinal artery syndrome in an adolescent with protein S deficiency. J Child Neurol 2001; 16:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/63\">",
"      Rothman SM, Nelson JS. Spinal cord infarction in a patient with sickle cell anemia. Neurology 1980; 30:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/64\">",
"      Ram S, Osman A, Cassar-Pullicino VN, et al. Spinal cord infarction secondary to intervertebral foraminal disease. Spinal Cord 2004; 42:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/65\">",
"      Lemke RP, Idiong N, al-Saedi S, et al. Spinal cord infarct after arterial switch associated with an umbilical artery catheter. Ann Thorac Surg 1996; 62:1532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/66\">",
"      Brown MS, Phibbs RH. Spinal cord injury in newborns from use of umbilical artery catheters: report of two cases and a review of the literature. J Perinatol 1988; 8:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/67\">",
"      Mori S, Sadoshima S, Tagawa K, et al. Massive spinal cord infarction with multiple paradoxical embolism: a case report. Angiology 1993; 44:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/68\">",
"      Hirose G, Kosoegawa H, Takado M, et al. Spinal cord ischemia and left atrial myxoma. Arch Neurol 1979; 36:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40631/abstract/69\">",
"      Petruzzellis M, Fraddosio A, Giorelli M, et al. Posterior spinal artery infarct due to patent foramen ovale: a case report. Spine (Phila Pa 1976) 2010; 35:E155.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1125 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-FFF4911520-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40631=[""].join("\n");
var outline_f39_43_40631=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      VASCULAR ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Anterior spinal artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Posterior spinal artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Venous system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Factors that modulate blood flow",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Aortic surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Aortic dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other aortic pathologies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Nonaortic surgeries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Fibrocartilaginous embolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Systemic hypotension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Vascular malformation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1125\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1125|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/49/8980\" title=\"figure 1\">",
"      Arterial supply of the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1125|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/36/5709\" title=\"table 1\">",
"      Causes of spinal cord infarct",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/44/5832?source=related_link\">",
"      Anatomy and localization of spinal cord disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37642?source=related_link\">",
"      Chronic complications of spinal cord injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/19/25914?source=related_link\">",
"      Clinical manifestations and diagnosis of aortic dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/42/32426?source=related_link\">",
"      Disorders affecting the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30230?source=related_link\">",
"      Spinal cord infarction: Clinical presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23333?source=related_link\">",
"      Spinal cord infarction: Prognosis and treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_43_40632="Eosinophilic meningitis";
var content_f39_43_40632=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Eosinophilic meningitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/43/40632/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40632/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/43/40632/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40632/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/43/40632/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40632/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/43/40632/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic meningitis is defined as the presence of more than 10",
"    <span class=\"nowrap\">",
"     eosinophils/mm3",
"    </span>",
"    in the cerebrospinal fluid (CSF),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    eosinophils accounting for more than 10 percent of CSF leukocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/1\">",
"     1",
"    </a>",
"    ]. Reliable detection of eosinophils in the CSF requires examination of centrifuged cell preparations stained with Wright's, Giemsa, or other appropriate stains. Eosinophils are found in the CSF in a limited number of diseases, including certain parasitic diseases and coccidioidal meningitis (",
"    <a class=\"graphic graphic_table graphicRef68987 \" href=\"mobipreview.htm?17/6/17516\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The etiologies of eosinophilic meningitis will be reviewed here, with emphasis on the parasitic causes of this condition.",
"   </p>",
"   <p>",
"    Most of the infectious agents that cause eosinophilic meningitis are parasites that endemic outside of North America and Europe. However, cases of eosinophilic meningitis due to these parasites may occur among travelers to both well-known and less known endemic regions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/5-11\">",
"     5-11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PARASITIC ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three important parasitic infections associated with eosinophilic meningitis: Angiostrongylus cantonensis, Baylisascaris procyonis, and Gnathostoma spinigerum. These are parasites for which humans are incidental hosts. Localization to nervous tissue is a typical manifestation of A. cantonensis and B. procyonis infection for both natural and incidental hosts. G. spinigerum can cause meningeal or extrameningeal infection. In general, human infection due to these organisms is self-limited because larvae do not replicate or mature to adult worms. Eosinophilic meningitis occurs as a result of larval migration within the nervous system; peripheral eosinophilia is also observed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Angiostrongylus cantonensis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiostrongylus cantonensis is the most common parasitic cause of eosinophilic meningitis. A. cantonensis larvae are neurotropic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic meningitis due to A. cantonensis occurs principally in Southeast Asia, particularly Thailand and Malaysia, and throughout the Pacific basin, including Indonesia, the Philippines, Taiwan, China, Japan, Papua New Guinea, Hawaii, and several smaller Pacific islands. Due in part to ship-borne dissemination of infected rats, the parasite has also been found outside of this broad area in regions of Africa, Australia, Cuba, Puerto Rico, and Jamaica, and has spread from New Orleans into other areas of Louisiana [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/12-19\">",
"     12-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The life cycle of A. cantonensis begins with eggs laid by adult worms in the pulmonary arteries of rats (",
"    <a class=\"graphic graphic_figure graphicRef50849 \" href=\"mobipreview.htm?37/32/38408\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/20\">",
"     20",
"    </a>",
"    ]. The first stage larvae migrate to the pharynx where they are swallowed and passed in the stool. These larvae are ingested by a snail or slug (intermediate host), in which larvae develop to a third stage. When the mollusk is ingested by the rat, the third-stage (infective larvae) migrate to the brain where they develop into adult worms; these worms return to the venous system and then the pulmonary arteries.",
"   </p>",
"   <p>",
"    Humans can acquire the infection by eating raw or undercooked snails or slugs infected with the parasite; they may also acquire the infection by eating raw produce containing a small snail or slug [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/21\">",
"     21",
"    </a>",
"    ]. Infection can also be transmitted by ingestion of infected paratenic animals, such as crab or freshwater shrimp. In humans, worms migrate to the brain (or rarely, the lungs) but do not produce eggs.",
"   </p>",
"   <p>",
"    Children who play in the dirt in endemic areas are at increased risk for infection. Visitors to endemic areas who partake of local foods are also at risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/22\">",
"     22",
"    </a>",
"    ]. Outbreaks of infection are uncommon even in endemic areas. One outbreak of eosinophilic meningitis due to A. cantonensis was reported among travelers returning from Jamaica [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;A. cantonensis larvae migrate into neurologic or ocular tissues. Neurologic symptoms develop 2 to 35 days following infection. Infection usually presents as transient meningitis or, less commonly, as severe disease involving the brain, spinal cord, and nerve roots [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/23\">",
"     23",
"    </a>",
"    ]. Excruciating headache is the most common presenting symptom in more than 90 percent of patients and is usually frontal, occipital, or bitemporal. The headache typically is relieved by lumbar puncture. Opening CSF pressures are often elevated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neck stiffness, nausea, vomiting, and paresthesias are also common; fever may be absent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/24\">",
"     24",
"    </a>",
"    ]. In an outbreak among 12 individuals, paresthesias or hyperesthesias of the arms, legs, trunk, or all three sites were present in 75 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/16\">",
"     16",
"    </a>",
"    ]. Paresthesias with residual areas of hyperesthesia can persist for several weeks, even after other symptoms have resolved. Paralysis of the extraocular muscles or facial nerves develops in 4 to 9 percent of patients, but generally resolves with time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. Fatalities are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/30\">",
"     30",
"    </a>",
"    ]; in one study of 484 cases of eosinophilic meningitis in Thailand, the mortality rate was less than 0.5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ocular involvement due to intravitreal larvae is less common than neurologic involvement and may be manifest by unilateral blurring of vision without signs of meningitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, the diagnosis of cerebral angiostrongyliasis is based upon the clinical presentation, presence of CSF eosinophilia, and an epidemiologic history of known or possible exposure to infective A. cantonensis larvae. The diagnosis requires the presence of CSF eosinophilia. The CSF is usually cloudy, but not grossly turbid or xanthochromic. The CSF leukocyte count ranges from about 20 to 5000",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    and is usually between 150 and 2000",
"    <span class=\"nowrap\">",
"     cells/mm3.",
"    </span>",
"    CSF eosinophilia exceeds 10 percent in approximately 95 percent of cases; it is usually 20 to 70 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. The CSF protein concentration is usually elevated, but the glucose concentration is normal or only minimally reduced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. The diagnosis does not depend on identifying the causative agent; A. cantonensis larvae have only rarely been recovered from the CSF antemortem.",
"   </p>",
"   <p>",
"    Peripheral blood eosinophilia usually accompanies the eosinophilic CSF pleocytosis; in the majority of patients it is &gt;3 percent. Blood eosinophilia does not correlate with CSF eosinophilia or with the clinical course.",
"   </p>",
"   <p>",
"    Computed tomography (CT) is generally unremarkable; the absence of focal lesions on CT scan helps to distinguish eosinophilic meningitis due to A. cantonensis from gnathostomiasis or neurocysticercosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/34\">",
"     34",
"    </a>",
"    ]. Magnetic resonance imaging (MRI) may demonstrate high signal intensities over the globus pallidus and cerebral peduncle on T1-weighted imaging, leptomeningeal enhancement, ventriculomegaly, and punctate areas of abnormal enhancement within the cerebral and cerebellar hemisphere on gadolinium-enhancing T1 imaging, and a hyperintense signal on T2-weighted images [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Enzyme-linked immunosorbent assay (ELISA) testing can be useful to confirm the diagnosis, but it is not widely available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/37\">",
"     37",
"    </a>",
"    ]. Newer immunoassays, also not widely available, can sensitively discriminate between eosinophilic meningitis due to A. cantonensis and gnathostomiasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of cerebral angiostrongyliasis consists of supportive measures. In the absence of reinfection, migrating larvae die over time and the accompanying inflammation subsides. Most patients with cerebral angiostrongyliasis have a self-limited course and recover completely.",
"   </p>",
"   <p>",
"    Analgesics, corticosteroids and periodic removal of CSF can relieve symptoms due to elevated intracranial pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/8\">",
"     8",
"    </a>",
"    ]. In one randomized trial including 110 patients with eosinophilic meningitis, those who received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    (60 mg daily for two weeks) were less likely to have persistent headache or require repeat lumbar puncture for symptomatic relief [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We advise against administration of anthelminthic agents for treatment of eosinophilic meningitis due to A. cantonensis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/39-44\">",
"     39-44",
"    </a>",
"    ]. Such treatment may elicit an inflammatory response due to dying organisms, and clinical exacerbation of neurologic symptoms following anthelminthic treatment has been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/42\">",
"     42",
"    </a>",
"    ]. In a randomized trial including 104 patients with eosinophilic meningitis due to A. cantonensis,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/6/24678?source=see_link\">",
"     albendazole",
"    </a>",
"    was no better than prednisolone alone for alleviation of headache [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the setting of ocular disease, treatment options include surgery or laser therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Gnathostomiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;G. spinigerum larvae can migrate in subcutaneous, visceral, or neural tissues; unlike A. cantonensis larvae, G. spinigerum larvae are not primarily neurotropic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6575813\">",
"    <span class=\"h3\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gnathostomiasis is endemic in Southeast Asia and parts of China and Japan; it also occurs in Europe, Central and South America, Africa, and the Middle East. Gnathostomiasis has also been described among travelers to endemic areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/7,11,45-47\">",
"     7,11,45-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The life cycle of gnathostomiasis begins with eggs laid by adult worms in the natural definitive host (pigs, cats, or dogs), where they reside in the gastric wall (",
"    <a class=\"graphic graphic_figure graphicRef59378 \" href=\"mobipreview.htm?43/13/44247\">",
"     figure 2",
"    </a>",
"    ). Eggs are passed in the stool and become embryonated in water.",
"   </p>",
"   <p>",
"    First stage larvae are ingested by a small crustacean (Cyclops, the first intermediate host), where second-stage larvae develop and are subsequently ingested by a fish, frog, or snake (second intermediate host). There they develop into third-stage larvae, which are ingested by a definitive host. Alternatively, the second intermediate host may be ingested by a paratenic host (a bird, snake, or frog), in which the larvae do not develop further but remain infective to the next predator.&nbsp;",
"   </p>",
"   <p>",
"    Humans become infected by eating undercooked fish, poultry, or snake meat containing third-stage larvae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/48\">",
"     48",
"    </a>",
"    ], or by drinking water containing infective second-stage larvae in Cyclops.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6575708\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gnathostoma larvae migrate in cutaneous, visceral, neural, or ocular tissues. Gnathostomiasis most frequently presents with migratory cutaneous swellings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/49\">",
"     49",
"    </a>",
"    ]; eosinophilic meningoencephalitis or inflammatory masses in visceral organs are less common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/47,50-56\">",
"     47,50-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Larval penetration into the brain usually occurs as a result of migration along a nerve tract. Affected patients typically present with sudden onset of severe radicular pain or headache as well as paresthesias in the trunk or a limb, followed shortly by paralysis of extremities or cranial nerves. Eosinophilic meningoencephalitis due to gnathostomiasis is usually more fulminant than infection due to angiostrongyliasis. In addition, tissue destruction and severe inflammation may result in acute cerebral hemorrhages, which can be large and rapidly fatal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6575731\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CSF is often xanthochromic or bloody with an eosinophilic pleocytosis. The CSF protein concentration is elevated but the glucose concentration is usually normal. Larvae can almost never be recovered from the CSF. Peripheral blood eosinophilia is often quite pronounced and greater than that seen in angiostrongyliasis.",
"   </p>",
"   <p>",
"    CT scans can demonstrate areas of hemorrhage, and gnathostomiasis may be mistaken for cerebral hemorrhage due to primary cerebrovascular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/34\">",
"     34",
"    </a>",
"    ]. MRI may demonstrate abnormal enhancement and enlargement in cauda equina gnathostomiasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/57\">",
"     57",
"    </a>",
"    ] and hemorrhage in intracerebral gnathostomiasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/58\">",
"     58",
"    </a>",
"    ]. Ultrasound biomicroscopy has been reported to be effective in diagnosis of intraocular gnathostomiasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serologic tests have been developed but are not readily available outside of highly endemic areas. Newer immunoassays can sensitively discriminate between eosinophilic meningitis due to A. cantonensis and gnathostomiasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6575806\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of CNS infection due to gnathostomiasis consists of supportive measures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/50,51,53,54,56\">",
"     50,51,53,54,56",
"    </a>",
"    ]. It is uncertain whether anthelminthic treatment of CNS gnathostomiasis is beneficial; there are concerns that it may be deleterious due to augmented inflammation from dying larvae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/8,47,60\">",
"     8,47,60",
"    </a>",
"    ]. There are no controlled trials evaluating the efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/6/24678?source=see_link\">",
"     albendazole",
"    </a>",
"    . Of nine patients reported to have been treated with varying regimens of albendazole, five fully recovered, two partially recovered and two patients did not recover [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/56\">",
"     56",
"    </a>",
"    ]. The use of corticosteroids is generally favored for suppression of inflammation, but there are no randomized control trials to ascertain their benefit and the optimal dosing is uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/56,61\">",
"     56,61",
"    </a>",
"    ]. The opening pressure is often elevated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/8\">",
"     8",
"    </a>",
"    ]; in such cases serial therapeutic lumbar punctures are appropriate.",
"   </p>",
"   <p>",
"    Treatment of cutaneous gnathostomiasis consists of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/6/24678?source=see_link\">",
"     albendazole",
"    </a>",
"    (400 mg orally twice daily for 21 days) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/13/32976?source=see_link\">",
"     ivermectin",
"    </a>",
"    (200",
"    <span class=\"nowrap\">",
"     mcg/kg/day",
"    </span>",
"    orally for two days); no controlled trials of these agents have been performed and patients should be monitored closely for relapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/55,62,63\">",
"     55,62,63",
"    </a>",
"    ]. In one study including 31 patients with cutaneous gnathostomiasis in Thailand, clinical response to a single dose of ivermectin was observed in only 41 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/64\">",
"     64",
"    </a>",
"    ]. In a study including 13 patients who developed gnathostomiasis following travel in Southeast Asia or Central America (including nine cases of cutaneous disease), neither ivermectin nor albendazole was fully effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/65\">",
"     65",
"    </a>",
"    ]. Relapse was observed in one patient treated with a single day of ivermectin and in 7 of 12 patients treated with albendazole (400 mg twice a day of albendazole for 21 days).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Baylisascariasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Baylisascaris procyonis is a parasite of raccoons that has tropism for the central nervous system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/66\">",
"     66",
"    </a>",
"    ]. The parasites are neurotropic in both natural and incidental hosts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1769301\">",
"    <span class=\"h3\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human infection due to B. procyonis is relatively uncommon. The parasite is prevalent in raccoons in the United States; proximity of raccoons to areas of human habitation provides opportunity for human infection. In a study in California, 28 to 49 percent of residential properties surveyed harbored for B. procyonis eggs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/67\">",
"     67",
"    </a>",
"    ]. Another study in Atlanta, Georgia noted that 22 percent of raccoons were infected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/68\">",
"     68",
"    </a>",
"    ]. Raccoons in Europe also harbor B. Procyonis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. In addition to raccoons, dogs and other procyonids, including pet kinkajous, can be infected with B. procyonis and serve as sources of human infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The life cycle of baylisascariasis begins with shedding of eggs laid by adult worms in the intestine of raccoons or dogs (",
"    <a class=\"graphic graphic_figure graphicRef68048 \" href=\"mobipreview.htm?43/44/44742\">",
"     figure 3",
"    </a>",
"    ). Eggs become infective after two to four weeks in the environment and are ingested by raccoons. Over 100 species of birds and mammals (especially rodents) can act as paratenic hosts for this parasite. Eggs ingested by these hosts hatch, and larvae penetrate the gut wall and migrate into various tissues where they encyst.&nbsp;The life cycle is completed when raccoons eat these hosts.&nbsp;Humans become infected when they ingest infective eggs from the environment; typically this occurs among young children playing in the dirt.",
"   </p>",
"   <p>",
"    Migration of the larvae through a variety of tissues (liver, heart, lungs, brain, eyes) results in visceral larva migrans and ocular larva migrans syndromes, similar to toxocariasis.&nbsp;Tropism of larvae for nervous tissues can lead to severe nervous tissue damage; the signs and symptoms of baylisascariasis are often severe.",
"   </p>",
"   <p>",
"    Eosinophilic meningoencephalitis due to B. procyonis is relatively rare. More than a dozen cases of human eosinophilic meningoencephalitis due to B. procyonis have been described in children who probably ingested dirt contaminated with parasite eggs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/66,72-75\">",
"     66,72-75",
"    </a>",
"    ]. Several children died and others had permanent neurologic sequelae. A pediatric case of spinal cord involvement has been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of subclinical cases is unknown.&nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1769362\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The larvae of B. procyonis are capable of invading the human spinal cord, brain, and eyes, resulting in permanent neurologic damage, blindness, or death.",
"   </p>",
"   <p>",
"    Ocular findings, diffuse unilateral subacute neuroretinitis and choroidal infiltrates in association with neurologic disease, have been described in two cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/74\">",
"     74",
"    </a>",
"    ]. Ocular involvement may occur in the absence of other neurologic manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1769257\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Baylisascariasis should be considered in patients, especially children, in the setting of meningitis, blood and CSF eosinophilia, and potential exposure to raccoon-contaminated soil who also have prominent blood and CSF eosinophilia. Definitive diagnosis requires morphologic identification of larvae on tissue biopsy or autopsy specimens (",
"    <a class=\"graphic graphic_picture graphicRef79639 \" href=\"mobipreview.htm?2/26/2469\">",
"     picture 1",
"    </a>",
"    ). Serologic tests based on excretory-secretory antigen ELISA assays and western blots have been used; although to obviate issues of antigenic cross-reactivity, a newer recombinant antigen-based ELISA offers better sensitivity and specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/78\">",
"     78",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1769264\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of anthelminthic treatment in the setting of established baylisascariasis infection is poor, but",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/6/24678?source=see_link\">",
"     albendazole",
"    </a>",
"    (25",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    orally for 20 days) has been shown to be preventative if administered promptly (up to three days) after exposure (ingestion of raccoon stool or contaminated soil) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. Steroid therapy is also appropriate for reduction of inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other parasites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other helminthic parasites whose eggs or larvae can localize to the CNS may elicit an eosinophilic pleocytosis. These include toxocariasis (visceral larva migrans) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/81\">",
"     81",
"    </a>",
"    ], trichinellosis, echinococcosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/82\">",
"     82",
"    </a>",
"    ], neurocysticercosis, fascioliasis, and paragonimiasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/83\">",
"     83",
"    </a>",
"    ]. (See related topics).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     NONPARASITIC INFECTIOUS ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coccidioidomycosis can cause eosinophilic meningitis; this is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/55/17271?source=see_link\">",
"     \"Coccidioidal meningitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Visceral myiasis (invasion of the central nervous system by larvae of cattle botflies) may elicit a CSF eosinophilia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/43/20152?source=see_link&amp;anchor=H8401226#H8401226\">",
"     \"Skin lesions in the returning traveler\", section on 'Myiasis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On rare occasions, CSF eosinophilia has been reported in case reports of viral, rickettsial, and bacterial infections, although it is uncertain whether these infections were etiologic or coincident, and the individual infectious agents are by no means commonly associated with eosinophilic meningitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     NONINFECTIOUS ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noninfectious etiologies of eosinophilic meningitis include hematologic disorders, adverse drug reactions, mechanical shunt malfunction and other causes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The hypereosinophilic syndromes are leukoproliferative disorders characterized by a sustained blood eosinophilia in excess of",
"    <span class=\"nowrap\">",
"     1500/mm3",
"    </span>",
"    without apparent parasitic, allergic, or other etiologies. While eosinophilic meningitis has been described in association with these disorders, it is relatively uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/85\">",
"     85",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/24/30090?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of the hypereosinophilic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neoplastic diseases, most frequently Hodgkin lymphoma, can have an associated eosinophilic CSF pleocytosis. CSF eosinophilia also has been noted infrequently with carcinomatous or non-Hodgkin lymphomatous meningitis, basophilic-eosinophilic meningitis with undifferentiated myeloproliferative disorders or leukemia, acute lymphocytic leukemia, disseminated glioblastoma, and an apparent paraneoplastic manifestation of a bronchogenic carcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/83\">",
"     83",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/48/24329?source=see_link\">",
"     \"Clinical features and diagnosis of leptomeningeal metastases from solid tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Eosinophilic meningitis may be observed as a result of medication including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    (and other NSAIDs),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , and intraventricular",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/83,86-90\">",
"     83,86-90",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sterile CSF eosinophilia has also been described after myelography with contrast agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/83\">",
"     83",
"    </a>",
"    ]. It can also accompany ventriculoperitoneal shunt implantation or malfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/91-93\">",
"     91-93",
"    </a>",
"    ]. In one series of children with ventriculoperitoneal shunts, approximately one-third had CSF eosinophilia (&gt;8 percent eosinophils) in the absence of peripheral blood eosinophilia; these patients were more likely to have shunt infections and require revision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/93\">",
"     93",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/17/39194?source=see_link\">",
"     \"Secondary involvement of the central nervous system by non-Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other conditions described with eosinophilic meningitis include sarcoidosis and cerebral eosinophilic granuloma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40632/abstract/94,95\">",
"     94,95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1770638\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Eosinophilic meningitis is defined as the presence of &gt;10",
"      <span class=\"nowrap\">",
"       eosinophils/mm3",
"      </span>",
"      in the cerebrospinal fluid (CSF)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      eosinophils accounting for &gt;10 percent of CSF leukocytes. Parasitic etiologies of eosinophilic meningitis include angiostrongyliasis, gnathostomiasis, and baylisascariasis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Parasitic etiologies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Humans are incidental hosts. The life cycle of angiostrongyliasis consists of transmission between rodents and snails or slugs (",
"      <a class=\"graphic graphic_figure graphicRef50849 \" href=\"mobipreview.htm?37/32/38408\">",
"       figure 1",
"      </a>",
"      ). The life cycle of gnathostomiasis consists of transmission between definitive hosts (pigs, cats, or dogs), intermediate hosts (Cyclops, fish, frogs, or snakes) and paratenic hosts (birds, snakes, or frogs) (",
"      <a class=\"graphic graphic_figure graphicRef59378 \" href=\"mobipreview.htm?43/13/44247\">",
"       figure 2",
"      </a>",
"      ). The life cycle of baylisascariasis consists of transmission between definitive hosts (raccoons or dogs) and paratenic hosts (other mammals and rodents) (",
"      <a class=\"graphic graphic_figure graphicRef68048 \" href=\"mobipreview.htm?43/44/44742\">",
"       figure 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6575813\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1769301\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is based upon the clinical presentation, presence of CSF eosinophilia, and epidemiologic history of exposure to infective larvae. Larvae can almost never be recovered from the CSF, but can be identified on tissue biopsy or autopsy specimens. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6575731\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1769257\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For treatment of angiostrongyliasis, we recommend NOT administering anthelminthic agents (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ); these may elicit an inflammatory response due to dying organisms. Analgesics, corticosteroids and periodic removal of CSF can relieve symptoms due to elevated intracranial pressure. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For treatment of CNS infection due to gnathostomiasis, we suggest NOT administering anthelminthic agents (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ); these may elicit an inflammatory response due to dying organisms. Analgesics and corticosteroids can alleviate symptoms. For treatment of cutaneous gnathostomiasis, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/6/24678?source=see_link\">",
"       albendazole",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/13/32976?source=see_link\">",
"       ivermectin",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ); dosing is outlined above. (See",
"      <a class=\"local\" href=\"#H6575806\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For treatment of baylisascariasis, we suggest NOT administering anthelminthic agents (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ); these may elicit an inflammatory response due to dying organisms. Analgesics and corticosteroids can alleviate symptoms. For asymptomatic individuals with known exposure to raccoon stool or contaminated soil, we suggest prophylactic treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/6/24678?source=see_link\">",
"       albendazole",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ); dosing is outlined above. (See",
"      <a class=\"local\" href=\"#H1769264\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Coccidioidomycosis is an important nonparasitic infectious cause of eosinophilic meningitis. Noninfectious etiologies of eosinophilic meningitis include hematologic disorders, adverse drug reactions, mechanical shunt malfunction and other causes. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Nonparasitic infectious etiologies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Noninfectious etiologies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/1\">",
"      Lo Re V 3rd, Gluckman SJ. Eosinophilic meningitis. Am J Med 2003; 114:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/2\">",
"      Hughes PA, Magnet AD, Fishbain JT. Eosinophilic meningitis: a case series report and review of the literature. Mil Med 2003; 168:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/3\">",
"      Weller PF. Eosinophilic meningitis. Am J Med 1993; 95:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/4\">",
"      Graeff-Teixeira C, da Silva AC, Yoshimura K. Update on eosinophilic meningoencephalitis and its clinical relevance. Clin Microbiol Rev 2009; 22:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/5\">",
"      Lo Re V 3rd, Gluckman SJ. Eosinophilic meningitis due to Angiostrongylus cantonensis in a returned traveler: case report and review of the literature. Clin Infect Dis 2001; 33:e112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/6\">",
"      B&auml;rtschi E, Bordmann G, Blum J, Rothen M. Eosinophilic meningitis due to Angiostrongylus cantonensis in Switzerland. Infection 2004; 32:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/7\">",
"      G&oacute;rgolas Md, Santos-O'Connor F, Unz&uacute; AL, et al. Cutaneous and medullar gnathostomiasis in travelers to Mexico and Thailand. J Travel Med 2003; 10:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/8\">",
"      Ramirez-Avila L, Slome S, Schuster FL, et al. Eosinophilic meningitis due to Angiostrongylus and Gnathostoma species. Clin Infect Dis 2009; 48:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/9\">",
"      Malvy D, Ezzedine K, Receveur MC, et al. Cluster of eosinophilic meningitis attributable to Angiostrongylus cantonensis infection in French policemen troop returning from the Pacific Islands. Travel Med Infect Dis 2008; 6:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/10\">",
"      Luessi F, Sollors J, Torzewski M, et al. Eosinophilic meningitis due to Angiostrongylus cantonensis in Germany. J Travel Med 2009; 16:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/11\">",
"      Herman JS, Wall EC, van-Tulleken C, et al. Gnathostomiasis acquired by British tourists in Botswana. Emerg Infect Dis 2009; 15:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/12\">",
"      Koo J, Pien F, Kliks MM. Angiostrongylus (Parastrongylus) eosinophilic meningitis. Rev Infect Dis 1988; 10:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/13\">",
"      Kliks MM, Palumbo NE. Eosinophilic meningitis beyond the Pacific Basin: the global dispersal of a peridomestic zoonosis caused by Angiostrongylus cantonensis, the nematode lungworm of rats. Soc Sci Med 1992; 34:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/14\">",
"      Campbell BG, Little MD. The finding of Angiostrongylus cantonensis in rats in New Orleans. Am J Trop Med Hyg 1988; 38:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/15\">",
"      Hochberg NS, Park SY, Blackburn BG, et al. Distribution of eosinophilic meningitis cases attributable to Angiostrongylus cantonensis, Hawaii. Emerg Infect Dis 2007; 13:1675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/16\">",
"      Slom TJ, Cortese MM, Gerber SI, et al. An outbreak of eosinophilic meningitis caused by Angiostrongylus cantonensis in travelers returning from the Caribbean. N Engl J Med 2002; 346:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/17\">",
"      Kim DY, Stewart TB, Bauer RW, Mitchell M. Parastrongylus (=Angiostrongylus) cantonensis now endemic in Louisiana wildlife. J Parasitol 2002; 88:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/18\">",
"      Senanayake SN, Pryor DS, Walker J, Konecny P. First report of human angiostrongyliasis acquired in Sydney. Med J Aust 2003; 179:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/19\">",
"      Prociv P, Carlisle MS. The spread of Angiostrongylus cantonensis in Australia. Southeast Asian J Trop Med Public Health 2001; 32 Suppl 2:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/20\">",
"      Escargots and eosinophilic meningitis. Lancet 1988; 2:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/21\">",
"      Tsai HC, Lee SS, Huang CK, et al. Outbreak of eosinophilic meningitis associated with drinking raw vegetable juice in southern Taiwan. Am J Trop Med Hyg 2004; 71:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/22\">",
"      Chau TT, Thwaites GE, Chuong LV, et al. Headache and confusion: the dangers of a raw snail supper. Lancet 2003; 361:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/23\">",
"      Petjom S, Chaiwun B, Settakorn J, et al. Angiostrongylus cantonensis infection mimicking a spinal cord tumor. Ann Neurol 2002; 52:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/24\">",
"      Tsai HC, Liu YC, Kunin CM, et al. Eosinophilic meningitis caused by Angiostrongylus cantonensis: report of 17 cases. Am J Med 2001; 111:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/25\">",
"      Schmutzhard E, Boongird P, Vejjajiva A. Eosinophilic meningitis and radiculomyelitis in Thailand, caused by CNS invasion of Gnathostoma spinigerum and Angiostrongylus cantonensis. J Neurol Neurosurg Psychiatry 1988; 51:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/26\">",
"      Kuberski T, Wallace GD. Clinical manifestations of eosinophilic memingitis due to Angiostrongylus cantonensis. Neurology 1979; 29:1566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/27\">",
"      Yii CY. Clinical observations on eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis on Taiwan. Am J Trop Med Hyg 1976; 25:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/28\">",
"      Bronstein JA, Thevenot J, Tourneux M. Eosinophilic meningitis in Tahiti: clinical study of 54 patients. N Z Med J 1978; 88:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/29\">",
"      Podwall D, Gupta R, Furuya EY, et al. Angiostrongylus cantonensis meningitis presenting with facial nerve palsy. J Neurol 2004; 251:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/30\">",
"      Lindo JF, Escoffery CT, Reid B, et al. Fatal autochthonous eosinophilic meningitis in a Jamaican child caused by Angiostrongylus cantonensis. Am J Trop Med Hyg 2004; 70:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/31\">",
"      Punyagupta S, Juttijudata P, Bunnag T. Eosinophilic meningitis in Thailand. Clinical studies of 484 typical cases probably caused by Angiostrongylus cantonensis. Am J Trop Med Hyg 1975; 24:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/32\">",
"      Patikulsila D, Ittipunkul N, Theerakittikul B. Intravitreal angiostrongyliasis: report of 2 cases. J Med Assoc Thai 2003; 86:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/33\">",
"      Kumar V, Kyprianou I, Keenan JM. Ocular Angiostrongyliasis: removal of a live nematode from the anterior chamber. Eye (Lond) 2005; 19:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/34\">",
"      Kanpittaya J, Sawanyawisuth K, Intapan PM, et al. A comparative study of neuroimaging features between human neuro-gnathostomiasis and angiostrongyliasis. Neurol Sci 2012; 33:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/35\">",
"      Tsai HC, Liu YC, Kunin CM, et al. Eosinophilic meningitis caused by Angiostrongylus cantonensis associated with eating raw snails: correlation of brain magnetic resonance imaging scans with clinical findings. Am J Trop Med Hyg 2003; 68:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/36\">",
"      Jin E, Ma D, Liang Y, et al. MRI findings of eosinophilic myelomeningoencephalitis due to Angiostrongylus cantonensis. Clin Radiol 2005; 60:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/37\">",
"      Eamsobhana P, Yoolek A, Kreethapon N. Blinded multi-laboratory evaluation of an in-house dot-blot ELISA kit for diagnosis of human parastrongyliasis. Southeast Asian J Trop Med Public Health 2003; 34:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/38\">",
"      Sawanyawisuth K, Sawanyawisuth K, Intapan PM, et al. Specificity of immunoblotting analyses in eosinophilic meningitis. Mem Inst Oswaldo Cruz 2011; 106:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/39\">",
"      Chotmongkol V, Sawanyawisuth K, Thavornpitak Y. Corticosteroid treatment of eosinophilic meningitis. Clin Infect Dis 2000; 31:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/40\">",
"      Chotmongkol V, Sawanyawisuth K. Clinical manifestations and outcome of patients with severe eosinophilic meningoencephalitis presumably caused by Angiostrongylus cantonensis. Southeast Asian J Trop Med Public Health 2002; 33:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/41\">",
"      Chotmongkol V, Wongjitrat C, Sawadpanit K, Sawanyawisuth K. Treatment of eosinophilic meningitis with a combination of albendazole and corticosteroid. Southeast Asian J Trop Med Public Health 2004; 35:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/42\">",
"      Hidelaratchi MD, Riffsy MT, Wijesekera JC. A case of eosinophilic meningitis following monitor lizard meat consumption, exacerbated by anthelminthics. Ceylon Med J 2005; 50:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/43\">",
"      Chotmongkol V, Kittimongkolma S, Niwattayakul K, et al. Comparison of prednisolone plus albendazole with prednisolone alone for treatment of patients with eosinophilic meningitis. Am J Trop Med Hyg 2009; 81:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/44\">",
"      Sawanyawisuth K, Sawanyawisuth K. Treatment of angiostrongyliasis. Trans R Soc Trop Med Hyg 2008; 102:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/45\">",
"      Moore DA, McCroddan J, Dekumyoy P, Chiodini PL. Gnathostomiasis: an emerging imported disease. Emerg Infect Dis 2003; 9:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/46\">",
"      Ligon BL. Gnathostomiasis: a review of a previously localized zoonosis now crossing numerous geographical boundaries. Semin Pediatr Infect Dis 2005; 16:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/47\">",
"      Herman JS, Chiodini PL. Gnathostomiasis, another emerging imported disease. Clin Microbiol Rev 2009; 22:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/48\">",
"      Magnino S, Colin P, Dei-Cas E, et al. Biological risks associated with consumption of reptile products. Int J Food Microbiol 2009; 134:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/49\">",
"      Bussaratid V, Dekumyoy P, Desakorn V, et al. Predictive factors for Gnathostoma seropositivity in patients visiting the Gnathostomiasis Clinic at the Hospital for Tropical Diseases, Thailand during 2000-2005. Southeast Asian J Trop Med Public Health 2010; 41:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/50\">",
"      Punyagupta S, Bunnag T, Juttijudata P. Eosinophilic meningitis in Thailand. Clinical and epidemiological characteristics of 162 patients with myeloencephalitis probably caused by Gnathostoma spinigerum. J Neurol Sci 1990; 96:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/51\">",
"      Boongird P, Phuapradit P, Siridej N, et al. Neurological manifestations of gnathostomiasis. J Neurol Sci 1977; 31:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/52\">",
"      Kawamura J, Kohri Y, Oka N. Eosinophilic meningoradiculomyelitis caused by Gnathostoma spinigerum. A case report. Arch Neurol 1983; 40:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/53\">",
"      Bunnag T, Comer DS, Punyagupta S. Eosinophilic myeloencephalitis caused by gnathostoma spinigerum. Neuropathology of nine cases. J Neurol Sci 1970; 10:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/54\">",
"      Brant-Zawadzki M, Wofsy CB, Schechter G. CT-evidence of subarachnoid hemorrhage due to presumed gnathostomiasis. West J Med 1982; 137:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/55\">",
"      Kraivichian K, Nuchprayoon S, Sitichalernchai P, et al. Treatment of cutaneous gnathostomiasis with ivermectin. Am J Trop Med Hyg 2004; 71:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/56\">",
"      Katchanov J, Sawanyawisuth K, Chotmongkoi V, Nawa Y. Neurognathostomiasis, a neglected parasitosis of the central nervous system. Emerg Infect Dis 2011; 17:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/57\">",
"      Sawanyawisuth K, Tiamkao S, Nitinavakarn B, et al. MR imaging findings in cauda equina gnathostomiasis. AJNR Am J Neuroradiol 2005; 26:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/58\">",
"      Sawanyawisuth K, Tiamkao S, Kanpittaya J, et al. MR imaging findings in cerebrospinal gnathostomiasis. AJNR Am J Neuroradiol 2004; 25:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/59\">",
"      Bhende M, Biswas J, Gopal L. Ultrasound biomicroscopy in the diagnosis and management of intraocular gnathostomiasis. Am J Ophthalmol 2005; 140:140.",
"     </a>",
"    </li>",
"    <li>",
"     Drugs for Parasitic Infections, Medical Letter, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/61\">",
"      Thanaviratananich S, Thanaviratananich S, Ngamjarus C. Corticosteroids for parasitic eosinophilic meningitis. Cochrane Database Syst Rev 2012; 10:CD009088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/62\">",
"      Nontasut P, Claesson BA, Dekumyoy P, et al. Double-dose ivermectin vs albendazole for the treatment of gnathostomiasis. Southeast Asian J Trop Med Public Health 2005; 36:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/63\">",
"      Bussaratid V, Krudsood S, Silachamroon U, Looareesuwan S. Tolerability of ivermectin in gnathostomiasis. Southeast Asian J Trop Med Public Health 2005; 36:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/64\">",
"      Bussaratid V, Desakorn V, Krudsood S, et al. Efficacy of ivermectin treatment of cutaneous gnathostomiasis evaluated by placebo-controlled trial. Southeast Asian J Trop Med Public Health 2006; 37:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/65\">",
"      Strady C, Dekumyoy P, Clement-Rigolet M, et al. Long-term follow-up of imported gnathostomiasis shows frequent treatment failure. Am J Trop Med Hyg 2009; 80:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/66\">",
"      Fox AS, Kazacos KR, Gould NS, et al. Fatal eosinophilic meningoencephalitis and visceral larva migrans caused by the raccoon ascarid Baylisascaris procyonis. N Engl J Med 1985; 312:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/67\">",
"      Roussere GP, Murray WJ, Raudenbush CB, et al. Raccoon roundworm eggs near homes and risk for larva migrans disease, California communities. Emerg Infect Dis 2003; 9:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/68\">",
"      Eberhard ML, Nace EK, Won KY, et al. Baylisascaris procyonis in the metropolitan Atlanta area. Emerg Infect Dis 2003; 9:1636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/69\">",
"      Bauer C. [Baylisascariosis (Baylisascaris procyonis)--a rare parasitic zoonosis in Europe]. Berl Munch Tierarztl Wochenschr 2011; 124:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/70\">",
"      Popioek M, Szczsna-Stakiewicz J, Bartoszewicz M, et al. Helminth parasites of an introduced invasive carnivore species, the raccoon ( Procyon lotor L.), from the Warta Mouth National Park (Poland). J Parasitol 2011; 97:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/71\">",
"      Centers for Disease Control and Prevention (CDC). Raccoon roundworms in pet kinkajous--three states, 1999 and 2010. MMWR Morb Mortal Wkly Rep 2011; 60:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/72\">",
"      Huff DS, Neafie RC, Binder MJ, et al. Case 4. The first fatal Baylisascaris infection in humans: an infant with eosinophilic meningoencephalitis. Pediatr Pathol 1984; 2:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/73\">",
"      Cunningham CK, Kazacos KR, McMillan JA, et al. Diagnosis and management of Baylisascaris procyonis infection in an infant with nonfatal meningoencephalitis. Clin Infect Dis 1994; 18:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/74\">",
"      Mets MB, Noble AG, Basti S, et al. Eye findings of diffuse unilateral subacute neuroretinitis and multiple choroidal infiltrates associated with neural larva migrans due to Bbaylisascaris procyonis. Am J Ophthalmol 2003; 135:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/75\">",
"      Sorvillo F, Ash LR, Berlin OG, Morse SA. Baylisascaris procyonis: an emerging helminthic zoonosis. Emerg Infect Dis 2002; 8:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/76\">",
"      Kelly TG, Madhavan VL, Peters JM, et al. Spinal cord involvement in a child with raccoon roundworm (Baylisascaris procyonis) meningoencephalitis. Pediatr Radiol 2012; 42:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/77\">",
"      Wise ME, Sorvillo FJ, Shafir SC, et al. Severe and fatal central nervous system disease in humans caused by Baylisascaris procyonis, the common roundworm of raccoons: a review of current literature. Microbes Infect 2005; 7:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/78\">",
"      Dangoudoubiyam S, Vemulapalli R, Ndao M, Kazacos KR. Recombinant antigen-based enzyme-linked immunosorbent assay for diagnosis of Baylisascaris procyonis larva migrans. Clin Vaccine Immunol 2011; 18:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/79\">",
"      Murray WJ, Kazacos KR. Raccoon roundworm encephalitis. Clin Infect Dis 2004; 39:1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/80\">",
"      Gavin PJ, Kazacos KR, Shulman ST. Baylisascariasis. Clin Microbiol Rev 2005; 18:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/81\">",
"      Robinson A, Tannier C, Magnaval JF. [Toxocara canis meningoradiculitis]. Rev Neurol (Paris) 2002; 158:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/82\">",
"      Bottieau E, David P, Dewitte O, Jacobs F. Eosinophilic meningitis following incomplete resection of a meningeal hydatid cyst. Scand J Infect Dis 2003; 35:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/83\">",
"      Weller PF, Liu LX. Eosinophilic meningitis. Semin Neurol 1993; 13:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/84\">",
"      Niggemann B, Bauer A, Jendroska K, Wahn U. Latex allergy as a cause of eosinophilia in cerebrospinal fluid in a child with a ventricular shunt. J Allergy Clin Immunol 1997; 100:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/85\">",
"      Moore PM, Harley JB, Fauci AS. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 1985; 102:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/86\">",
"      Quinn JP, Weinstein RA, Caplan LR. Eosinophilic meningitis and ibuprofen therapy. Neurology 1984; 34:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/87\">",
"      Asperilla MO, Smego RA Jr. Eosinophilic meningitis associated with ciprofloxacin. Am J Med 1989; 87:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/88\">",
"      Patey O, Lacheheb A, Dellion S, et al. A rare case of cotrimoxazole-induced eosinophilic aseptic meningitis in an HIV-infected patient. Scand J Infect Dis 1998; 30:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/89\">",
"      Grabb PA, Albright AL. Intraventricular vancomycin-induced cerebrospinal fluid eosinophilia: report of two patients. Neurosurgery 1992; 30:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/90\">",
"      Mine S, Sato A, Yamaura A, et al. Eosinophilia of the cerebrospinal fluid in a case of shunt infection: case report. Neurosurgery 1986; 19:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/91\">",
"      Traynelis VC, Powell RG, Koss W, et al. Cerebrospinal fluid eosinophilia and sterile shunt malfunction. Neurosurgery 1988; 23:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/92\">",
"      Kennedy CR, Singer HS. Eosinophilia of the cerebrospinal fluid: late reaction to a silastic shunt. Dev Med Child Neurol 1988; 30:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/93\">",
"      Tung H, Raffel C, McComb JG. Ventricular cerebrospinal fluid eosinophilia in children with ventriculoperitoneal shunts. J Neurosurg 1991; 75:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/94\">",
"      Scott TF. A new cause of cerebrospinal fluid eosinophilia: neurosarcoidosis. Am J Med 1988; 84:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40632/abstract/95\">",
"      Sivalingam S, Corkill G, Ellis WG, Claiche JR. Focal eosinophilic granuloma of the temporal lobe. Case report. J Neurosurg 1977; 47:941.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5729 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-110.170.48.130-053DC9DE2B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40632=[""].join("\n");
var outline_f39_43_40632=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1770638\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PARASITIC ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Angiostrongylus cantonensis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Gnathostomiasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6575813\">",
"      - Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6575708\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6575731\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6575806\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Baylisascariasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1769301\">",
"      - Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1769362\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1769257\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1769264\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other parasites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      NONPARASITIC INFECTIOUS ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      NONINFECTIOUS ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1770638\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5729\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5729|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/32/38408\" title=\"figure 1\">",
"      Angiostrongylus life cycle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/13/44247\" title=\"figure 2\">",
"      Gnathostomiasis life cycle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/44/44742\" title=\"figure 3\">",
"      Baylisascariasis life cycle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5729|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/26/2469\" title=\"picture 1\">",
"      Baylisascariasis biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5729|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/6/17516\" title=\"table 1\">",
"      Causes eosinophilic meningitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/48/24329?source=related_link\">",
"      Clinical features and diagnosis of leptomeningeal metastases from solid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/24/30090?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of the hypereosinophilic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/55/17271?source=related_link\">",
"      Coccidioidal meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/17/39194?source=related_link\">",
"      Secondary involvement of the central nervous system by non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/43/20152?source=related_link\">",
"      Skin lesions in the returning traveler",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_43_40633="Clinical manifestations and diagnosis of cholangiocarcinoma";
var content_f39_43_40633=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of cholangiocarcinoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/43/40633/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40633/contributors\">",
"     Robert C Lowe, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40633/contributors\">",
"     Nezam H Afdhal, MD, FRCPI",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40633/contributors\">",
"     Christopher D Anderson, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/43/40633/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40633/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/43/40633/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40633/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/43/40633/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/43/40633/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholangiocarcinomas (bile duct cancers) arise from the epithelial cells of the bile ducts. Although they are rare in the United States, these cancers are highly lethal because most are locally advanced at presentation.",
"   </p>",
"   <p>",
"    Biliary tract malignancies were traditionally divided into cancers of the gallbladder, the extrahepatic ducts, and the ampulla of Vater, while intrahepatic tumors were classified as primary liver cancers. However, more recently, the term cholangiocarcinoma has been used to refer to bile duct cancers arising in the intrahepatic, perihilar, or distal (extrahepatic) biliary tree, exclusive of gallbladder or ampulla of Vater (",
"    <a class=\"graphic graphic_figure graphicRef52489 \" href=\"mobipreview.htm?19/12/19651\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Intrahepatic cholangiocarcinomas can originate from either small intrahepatic ductules (peripheral cholangiocarcinomas) or large intrahepatic ducts proximal to the bifurcation of the right and left hepatic ducts. In turn, the extrahepatic bile ducts are divided into perihilar (including the confluence itself) and distal segments, with the transition occurring at the point where the common bile duct lies posterior to the duodenum (",
"    <a class=\"graphic graphic_figure graphicRef52489 \" href=\"mobipreview.htm?19/12/19651\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/1\">",
"     1",
"    </a>",
"    ]. Cancers arising in the perihilar region have been further classified according to the pattern of involvement of the hepatic ducts (the Bismuth-Corlette classification) (",
"    <a class=\"graphic graphic_figure graphicRef75886 \" href=\"mobipreview.htm?0/36/582\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Tumors involving the proper hepatic duct bifurcation (hilar cholangiocarcinoma) are collectively referred to as Klatskin tumors.",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of cholangiocarcinoma will be discussed here. The epidemiology, pathogenesis, classification, and treatment are reviewed separately. Cancers of the gall bladder and ampulla of Vater are discussed as separate disease processes, although these structures are part of the biliary drainage system. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43881?source=see_link\">",
"     \"Epidemiology, pathogenesis, and classification of cholangiocarcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/33/25114?source=see_link\">",
"     \"Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/58/34728?source=see_link\">",
"     \"Treatment options for locally advanced cholangiocarcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/52/43848?source=see_link\">",
"     \"Ampullary carcinoma: Epidemiology, clinical manifestations, diagnosis and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholangiocarcinomas usually become symptomatic when the tumor obstructs the biliary drainage system, causing painless jaundice. Common symptoms include pruritus (66 percent), abdominal pain (30 to 50 percent), weight loss (30 to 50 percent), and fever (up to 20 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The pain is generally described as a constant dull ache in the right upper quadrant. Cholangitis is an unusual presentation. Patients with primary sclerosing cholangitis and cholangiocarcinoma tend to present with a declining performances status and increasing cholestasis. Other symptoms related to biliary obstruction include clay-colored stools and dark urine. Physical signs include jaundice (90 percent), hepatomegaly (25 to 40 percent), or a right upper quadrant mass (10 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/4\">",
"     4",
"    </a>",
"    ]. A palpable gallbladder, caused by obstruction distal to the takeoff of the cystic duct (Courvoisier's sign), occurs rarely.",
"   </p>",
"   <p>",
"    Laboratory studies typically suggest biliary obstruction, with elevations in total (often above 10",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    and direct bilirubin, alkaline phosphatase (usually increased two- to 10-fold), 5'-nucleotidase, and gamma-glutamyltransferase. The last two findings confirm the hepatobiliary origin of the excess alkaline phosphatase. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/57/19353?source=see_link\">",
"     \"Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5&rsquo;-nucleotidase, gamma-glutamyl transpeptidase)\"",
"    </a>",
"    .) Transaminase levels (aspartate aminotransferase [AST] and alanine aminotransferase [ALT]) may be initially normal; chronic biliary obstruction often leads to liver dysfunction and a pattern consistent with injury, with elevated transaminases and a prolonged prothrombin time.",
"   </p>",
"   <p>",
"    Cholangiocarcinomas involving only the intrahepatic ducts (fewer than 10 percent of all cholangiocarcinomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/6\">",
"     6",
"    </a>",
"    ]) may present differently. Affected patients are less likely to be jaundiced. Instead, they usually have a history of dull right upper quadrant pain and weight loss, an elevated serum alkaline phosphatase, and normal or only slightly elevated serum bilirubin levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Making a definitive tissue diagnosis of cholangiocarcinoma preoperatively can be difficult. This is an important clinical issue since up to one-third of patients with symptoms and cholangiogram suggestive of a bile duct malignancy will have either benign fibrosing disease or another malignancy with metastases that obstruct the bile ducts.",
"   </p>",
"   <p>",
"    Preoperative evaluation typically includes right upper quadrant ultrasound, dynamic CT scan, MRCP (in centers with technical expertise in this procedure),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ERCP with",
"    <span class=\"nowrap\">",
"     brushing/biopsy.",
"    </span>",
"    Tumor markers such as CA 19-9 can be useful in conjunction with biopsy or brushings to confirm the diagnosis. If a tissue diagnosis cannot be confirmed, ultrasound or CT-guided percutaneous biopsy should be considered. Even after extensive diagnostic work-up, many patients still require surgical exploration to confirm the diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111257965\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the triad of cholestasis, abdominal pain, and weight loss is suggestive of either a hepatobiliary or pancreatic malignancy, the differential diagnosis includes choledocholithiasis, benign bile duct strictures (usually postoperative), sclerosing cholangitis, or compression of the common bile duct by either chronic pancreatitis or pancreatic cancer. Up to one-third of patients with symptoms and cholangiogram suggestive of a bile duct malignancy will have either benign fibrosing disease or another malignancy with metastases that obstruct the bile ducts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Liver biochemical tests are of little use in differentiating among these conditions since all can be associated with jaundice and an elevated alkaline phosphatase. One useful clinical finding is that cholangiocarcinoma is often associated with intermittent rather than steadily progressive jaundice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Tumor markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not specific for cholangiocarcinoma, the presence of certain tumor markers in the serum or bile of patients with cholangiocarcinoma may be of diagnostic value. Most of the studies in this area have been geared toward identifying cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC). Such patients have an increased incidence of cholangiocarcinoma, which is difficult to diagnose radiographically due to the underlying pathology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43881?source=see_link\">",
"     \"Epidemiology, pathogenesis, and classification of cholangiocarcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The list of potential serum and bile tumor markers continues to grow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/9\">",
"     9",
"    </a>",
"    ]; CEA and CA 19-9 are the two markers that have been best studied, although their diagnostic utility is limited due to significant overlap with benign disease and low sensitivity for early stage disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     CEA",
"    </span>",
"    &nbsp;&mdash;&nbsp;By themselves, serum levels of carcinoembryonic antigen (CEA) are neither sufficiently sensitive nor specific to diagnose cholangiocarcinoma. Many conditions other than cholangiocarcinoma can increase serum levels of CEA. Noncancer-related causes of an elevated CEA include gastritis, peptic ulcer disease, diverticulitis, liver disease, chronic obstructive pulmonary disease, diabetes, and any acute or chronic inflammatory state.",
"   </p>",
"   <p>",
"    One large series evaluated serum CEA levels in 333 patients with PSC, of whom 44 (13 percent) were diagnosed with cholangiocarcinoma either by histologic confirmation or at least one year of clinical follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/10\">",
"     10",
"    </a>",
"    ]. A serum CEA level &gt;5.2",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    had a sensitivity and specificity of 68 (95% CI 48 to 84 percent) and 82 percent (95% CI 74 to 88 percent), respectively.",
"   </p>",
"   <p>",
"    Biliary levels of CEA have also been evaluated. In one report, the biliary CEA concentration was elevated approximately five-fold in patients with cholangiocarcinoma compared to those with benign strictures; patients with PSC or choledochal cysts without malignancy had intermediate values [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some reports suggest that detection rates for cholangiocarcinoma in the setting of PSC may be higher when CEA is used together with CA 19-9.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     CA 19-9",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum levels of cancer antigen (CA) 19-9 are widely used, particularly for detecting cholangiocarcinoma in patients with PSC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/10,12-15\">",
"     10,12-15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/63/22521?source=see_link\">",
"     \"Clinical manifestations and diagnosis of primary sclerosing cholangitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, there are limitations to the use of serum CA 19-9 as a tumor marker for cholangiocarcinoma in this setting, as evidenced by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The specificity of CA 19-9 is limited. CA 19-9 is frequently elevated in patients with various benign pancreaticobiliary disorders, including cholangitis, and other malignancies, including pancreatic cancer (",
"      <a class=\"graphic graphic_table graphicRef52557 \" href=\"mobipreview.htm?3/11/3259\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41610?source=see_link&amp;anchor=H1620032#H1620032\">",
"       \"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer\", section on 'Role of tumor markers'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Some tumors produce low levels or no CA 19-9. In the series discussed above, a level of &gt;180",
"      <span class=\"nowrap\">",
"       U/mL",
"      </span>",
"      had a sensitivity of only 67 percent; the specificity of such a high level, though, was 98 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 103 patients without PSC, the sensitivity of a serum CA 19-9 level of &gt;100",
"      <span class=\"nowrap\">",
"       U/mL",
"      </span>",
"      in diagnosing cholangiocarcinoma (n=36) was 53 percent, and the true negative rates for nonmalignant liver disease (n=41) and for benign bile duct stricture (n=26) were 76 percent and 92 percent, respectively. Patients with unresectable cholangiocarcinoma had significantly a greater mean CA 19-9 concentration compared to those with resectable cholangiocarcinoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a report of 218 patients with PSC (14 with cholangiocarcinoma), a serum CA 19-9 level of 129",
"      <span class=\"nowrap\">",
"       U/mL",
"      </span>",
"      was 79 percent sensitive and 99 percent specific for the diagnosis of cholangiocarcinoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/12\">",
"       12",
"      </a>",
"      ]. However, the positive predictive value (the likelihood that a patient with PSC and a CA 19-9 level of 129",
"      <span class=\"nowrap\">",
"       U/mL",
"      </span>",
"      or more has cholangiocarcinoma) was only 57 percent. A cutoff of 63.2",
"      <span class=\"nowrap\">",
"       U/mL",
"      </span>",
"      provided a sensitivity, specificity, and positive predictive value of 90, 98, and 42 percent, respectively. However, only advanced cases were detected by a rising CA 19-9; two of 14 patients with cholangiocarcinoma were candidates for curative therapy.",
"     </li>",
"     <li>",
"      In a later series that focused on 73 patients with PSC, a substantial proportion (37 percent) of those who had a CA 19-9 of greater than 129",
"      <span class=\"nowrap\">",
"       U/mL",
"      </span>",
"      did not have cholangiocarcinoma (or develop cholangiocarcinoma during up to 30 months of follow-up) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/16\">",
"       16",
"      </a>",
"      ]. In some cases, the elevated CA 19-9 could be attributed to endoscopic therapy or recurrent bacterial cholangitis, but in many it was not explained.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The optimal cutoff value that best discriminates between benign or malignant biliary tract disease is influenced by the presence of cholangitis (ie, fever, leukocytosis, and right upper quadrant pain) and cholestasis (defined as a serum bilirubin &gt;3",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [51.3",
"    <span class=\"nowrap\">",
"     &micro;mol/L]).",
"    </span>",
"    In one report, a CA 19-9 cutoff value of &ge;37",
"    <span class=\"nowrap\">",
"     U/mL",
"    </span>",
"    was 78 percent sensitive and 83 percent specific for malignant disease in patients with neither cholangitis or cholestasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/14\">",
"     14",
"    </a>",
"    ]. In contrast, using the same cutoff in the presence of either condition decreased the specificity to only 42 percent. In patients with cholestasis or cholangitis, increasing the cutoff value to &ge;300",
"    <span class=\"nowrap\">",
"     U/mL",
"    </span>",
"    was optimal for increasing specificity (87 percent) but at the expense of sensitivity (approximately 40 percent). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22823?source=see_link\">",
"     \"Glossary of common biostatistical and epidemiological terms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, in patients with symptoms of acute cholangitis, serum CA 19-9 concentrations should ideally be reevaluated after recovery. We typically use a CA 19-9 value &ge;200",
"    <span class=\"nowrap\">",
"     U/mL",
"    </span>",
"    to increase suspicion for a cholangiocarcinoma in patients with PSC, especially in the presence of a dominant hilar stricture.",
"   </p>",
"   <p>",
"    If initially elevated, serum CA 19-9 levels may also be useful for following the effect of treatment and to detect disease recurrence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Combined CEA and CA 19-9",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of a combined index of serum CA 19-9 and CEA (CA 19-9 + [CEA x 40]) has also been proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/15\">",
"     15",
"    </a>",
"    ]. In one series, this index correctly identified 10 of 15 patients with cholangiocarcinoma, including 6 of 11 with radiographically occult disease; there were no false positives. However, in a more recent study of 72 patients with PSC, the use of CA 19-9 alone (cutoff value &ge;37",
"    <span class=\"nowrap\">",
"     U/mL)",
"    </span>",
"    was 63 percent sensitive for detecting cholangiocarcinoma, while the sensitivity of the combined CA 19-9",
"    <span class=\"nowrap\">",
"     /CEA",
"    </span>",
"    index was only 33 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/17\">",
"     17",
"    </a>",
"    ]. In the series mentioned above that focused on individuals with PSC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/10\">",
"     10",
"    </a>",
"    ], 45 patients (eight of whom had cholangiocarcinoma) had both tests. Using the cutoff values of CEA &gt;5.2",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    and CA 19-9 &gt;180",
"    <span class=\"nowrap\">",
"     U/mL,",
"    </span>",
"    the sensitivity and specificity were 100 percent (95% CI 65 to 100 percent) and 78 percent (95% CI 63 to 90 percent), respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Biliary insulin-like growth factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholangiocarcinoma cells secrete insulin-like growth factor I making it potentially useful for diagnosis. A pilot study found that biliary levels were highly accurate in discriminating extrahepatic cholangiocarcinoma from pancreatic cancer and benign biliary abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/18\">",
"     18",
"    </a>",
"    ]. Additional studies are needed to validate these findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Fluorescence in situ hybridization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluorescence in situ hybridization (FISH) is a cytological test using labeled DNA probes to detect abnormal loss or gain of chromosomes or chromosomal loci. Its role in diagnosis of cholangiocarcinoma is described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19816?source=see_link\">",
"     \"Endoscopic methods for the diagnosis of pancreatobiliary neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Radiographic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographic studies are essential in establishing the cause of jaundice, whether bile duct strictures are benign or malignant, and planning management in patients with suspected cholangiocarcinoma. Diagnosis of a cholangiocarcinoma can be challenging, particularly in patients with PSC. In such cases, mass lesions are infrequently identified on imaging, and patients often do not develop significant intrahepatic biliary dilatation. A high index of suspicion and multidisciplinary investigative procedures are needed.",
"   </p>",
"   <p>",
"    Most jaundiced patients undergo initial transabdominal ultrasound (US) to confirm biliary ductal dilatation, localize the site of the obstruction, and exclude gallstones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/19\">",
"     19",
"    </a>",
"    ]. The sequence of subsequent evaluation is slightly different for hilar as compared to distal lesions. For hilar lesions (intrahepatic ductal dilatation with normal caliber extrahepatic ducts), magnetic resonance cholangiopancreatography (MRCP) is emerging as the imaging technique of choice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/20\">",
"     20",
"    </a>",
"    ], while the use of invasive cholangiography, particularly ERCP, is diminishing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic accuracy of US was shown in a study of 429 patients who presented with obstructive jaundice over a ten year period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/21\">",
"     21",
"    </a>",
"    ]. US demonstrated ductal obstruction in 89 percent, and its sensitivity for localizing the site of obstruction was 94 percent.",
"   </p>",
"   <p>",
"    Intrahepatic cholangiocarcinomas appear as a mass lesion on US. Perihilar and extrahepatic cancers may not be detected, especially if small, but indirect signs (ductal dilatation throughout the obstructed liver segments) may point toward the diagnosis. An obstructing lesion is suggested by ductal dilatation (&gt;6 mm in normal adults) in the absence of stones. Proximal lesions cause dilation of the intrahepatic ducts alone, while both intrahepatic and extrahepatic ducts are dilated with more distal lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/19\">",
"     19",
"    </a>",
"    ]. The exact location of the tumor can be suggested if there is an abrupt change in ductal diameter.",
"   </p>",
"   <p>",
"    Specific US findings are associated with various types of cholangiocarcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Klatskin tumors often appear as segmental dilatation and nonunion of the right and left ducts",
"     </li>",
"     <li>",
"      Papillary tumors appear as polypoid intraluminal masses. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43881?source=see_link\">",
"       \"Epidemiology, pathogenesis, and classification of cholangiocarcinoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nodular cholangiocarcinomas appear as discrete smooth masses with associated mural thickening.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As noted above, the bile ducts may not be visibly dilated in cholangiocarcinomas with underlying PSC or cirrhosis.",
"   </p>",
"   <p>",
"    An important adjunct to diagnostic US is the ability to evaluate vascular involvement (ie, compression, encasement, or thrombosis of the portal vein, encasement or occlusion of the hepatic artery) using duplex ultrasound (color Doppler). Invasion into the portal vein or hepatic artery is an important indicator of unresectability. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/33/25114?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy\", section on 'Criteria for resectability'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one report, preoperative US detected 13 of 16 cases involving the hepatic vein (81 percent sensitivity, 97 percent specificity, and 87 percent positive predictive value) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/23\">",
"     23",
"    </a>",
"    ]. These results were comparable to those found during magnetic resonance imaging (MRI) (75 percent sensitivity). In a second series of 41 patients with cholangiocarcinoma and demonstrated portal vein involvement at surgery, US detected 38 preoperatively (93 percent sensitivity, 99 percent specificity, 97 percent and 98 percent positive and negative predictive values, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/24\">",
"     24",
"    </a>",
"    ]. These results were comparable to those found by angiography with computed tomographic arterial portography (CTAP, 90 percent sensitivity). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/32/18950?source=see_link\">",
"     \"Computed tomography of the hepatobiliary tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     CT scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of its widespread availability, CT is commonly obtained in patients with suspected biliary malignancy. It is useful for detecting intrahepatic tumors, the level of biliary obstruction, and the presence of liver atrophy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/32/18950?source=see_link\">",
"     \"Computed tomography of the hepatobiliary tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The site of intrahepatic ductal dilatation is often suggestive of the location of the obstructing lesion:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ductal dilatation in both hepatic lobes with a contracted gallbladder or nonunion of the right and left hepatic ducts with or without a visibly thickened wall suggests a Klatskin tumor. In contrast, a distended gallbladder without dilated intrahepatic or extrahepatic ducts suggests cystic duct stones or tumor. A distended gallbladder with dilated intrahepatic and extrahepatic ducts is more typical of tumors involving the common bile duct, the ampulla of Vater, or pancreatic cancer. Although cholangiocarcinoma is generally less common than pancreatic carcinoma, it should be suspected in a patient with a specific risk factor (eg, PSC). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43881?source=see_link\">",
"       \"Epidemiology, pathogenesis, and classification of cholangiocarcinoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dilatation of the ducts within an atrophied hepatic lobe, in conjunction with a hypertrophic contralateral lobe (the atrophy-hypertrophy complex) suggests invasion of the branch portal vein [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Contrast-enhanced triple phase helical or dynamic CT is a sensitive means of distinguishing benign from malignant intrahepatic bile duct strictures (particularly during the portal venous phase) and visualizing the pertinent nodal basins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. The detection of a hypodense hepatic lesion with peripheral (rim) enhancement, biliary dilatation, and contrast enhancement on delayed images is highly suggestive of a peripheral intrahepatic cholangiocarcinoma. In one study, 24 patients with 25 biopsy-proven peripheral cholangiocarcinomas had preoperative CT scans (four nonhelical, 21 helical, and all with portal venous phase images), all tumors were globally hypodense during the portal venous phase and 70 percent hyperattenuated on delayed images [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/26\">",
"     26",
"    </a>",
"    ]. However, some small mass-forming intrahepatic cholangiocarcinomas are arterially enhancing and may mimic hepatocellular carcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/10/34986?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical features and diagnosis of primary hepatocellular carcinoma\", section on 'Abdominal CT'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Even multiphasic CT is limited in its ability to establish the extent of intraductal tumor spread and resectability, particularly for the periductal infiltrative type of tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In one report of 29 patients with histologically-proven hilar cholangiocarcinoma, all of whom underwent multiphasic CT (arterial and portal venous phase), resectability was correctly predicted in only 60 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite this, dynamic CT may provide more information regarding resectability than does MRI. As an example, the MRI and dynamic CT images of 20 patients with intrahepatic cholangiocarcinoma were compared [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/31\">",
"     31",
"    </a>",
"    ]. The extent of tumor enhancement was similar with both imaging methods, and biliary ductal dilatation was detected in 65 percent by either method. However, the relationship of the tumor to the vessels and surrounding organs was more easily evaluated on CT as opposed to MRI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For perihilar tumors, CT also has limited sensitivity for extraregional nodal disease (ie, metastases to the periaortic, pericaval or celiac artery lymph nodes [(",
"    <a class=\"graphic graphic_table graphicRef51131 \" href=\"mobipreview.htm?4/11/4285\">",
"     table 2",
"    </a>",
"    )]) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/32\">",
"     32",
"    </a>",
"    ]. On the other hand, abdominal lymphadenopathy is a common finding in PSC, and its presence on a preoperative CT scan does not necessarily indicate malignant involvement. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43881?source=see_link\">",
"     \"Epidemiology, pathogenesis, and classification of cholangiocarcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     MRCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive technique for evaluating the intrahepatic and extrahepatic bile ducts and the pancreatic duct that is emerging as an excellent tool for the preoperative assessment of biliary tract cancers. Unlike conventional ERCP, MRCP does not require contrast material to be administered into the ductal system.",
"   </p>",
"   <p>",
"    MRCP has advantages over CT as well. In addition to imaging the liver parenchyma and intrahepatic lesions, it can create a three dimensional image of the biliary tree (allowing assessment of the bile ducts both above and below a stricture), and vascular structures (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73964 \" href=\"mobipreview.htm?9/47/9968\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72880 \" href=\"mobipreview.htm?13/6/13423\">",
"     image 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/51/23351?source=see_link\">",
"     \"Magnetic resonance cholangiopancreatography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cholangiocarcinomas appear as hypointense lesions on T1-weighted images that are hyperintense on T2-weighted images [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/33\">",
"     33",
"    </a>",
"    ]. T2-weighted images may also show central hypointensity corresponding to areas of fibrosis. Dynamic images show peripheral enhancement followed by progressive and concentric filling in of the tumor with contrast material. Pooling of contrast on delayed images is suggestive of a peripheral cholangiocarcinoma.",
"   </p>",
"   <p>",
"    MRCP provides information about disease extent and potential resectability that is at least comparable to that obtained using CT, cholangiography, and angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/34-40\">",
"     34-40",
"    </a>",
"    ]. In a series comparing MRCP with ERCP in 40 patients with malignant perihilar obstruction, both techniques detected 100 percent of biliary obstructions equally. However, MRCP was superior in definition of anatomical extent of tumor and the cause of jaundice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The place of MRCP in the preoperative evaluation of suspected cholangiocarcinoma is evolving and somewhat center-dependent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Some consider that the combination of MRCP and spiral CT have largely supplanted invasive cholangiography in patients with obstructive jaundice thought due to a proximal lesion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/41\">",
"     41",
"    </a>",
"    ]. However, one of the disadvantages of MRCP is that current technology does not allow any intervention to be performed, such as stone extraction, stent insertion, or biopsy. In addition, in approximately 20 percent of cases, MRCP understages disease extent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/36\">",
"     36",
"    </a>",
"    ]. Finally, this procedure requires dedicated radiology personnel and a high level of technical expertise. If at all possible, MRCP should be performed before biliary drainage, since evaluation for biliary pathology is more difficult if the biliary tree is collapsed from a preceding biliary drainage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Cholangiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholangiography entails an injection of radiographic contrast material to opacify the bile ducts; it can be performed by endoscopic retrograde pancreatography (ERCP) or via a percutaneous approach (percutaneous transhepatic cholangiogram [PTC]). Preoperative cholangiography may be indicated either diagnostically or therapeutically for patients with biliary obstruction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19816?source=see_link&amp;anchor=H2#H2\">",
"     \"Endoscopic methods for the diagnosis of pancreatobiliary neoplasms\", section on 'Endoscopic retrograde cholangiopancreatography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/39/37491?source=see_link\">",
"     \"Percutaneous transhepatic cholangiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, MRCP and dynamic CT have largely replaced invasive cholangiography in patients thought to have a hilar cholangiocarcinoma in centers with expertise in this technique [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/41\">",
"     41",
"    </a>",
"    ]. However, cholangiography may still be indicated if the suspected level of obstruction is distal, or if preoperative drainage of the biliary tree is needed. Many surgeons still rely on images from ERCP or PTC rather than MRCP to determine resectability. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/33/25114?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy\", section on 'Criteria for resectability'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The choice of modality depends in part upon the level of endoscopic or radiologic expertise available to the clinician. However, ERCP is preferred in patients with PSC since the marked stricturing of the intrahepatic biliary tree makes a percutaneous approach difficult. Conversely, PTC is generally preferred for imaging the more proximal biliary system if there is complete obstruction of the distal biliary tree. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/39/37491?source=see_link\">",
"     \"Percutaneous transhepatic cholangiography\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19816?source=see_link\">",
"     \"Endoscopic methods for the diagnosis of pancreatobiliary neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the past, a presumptive diagnosis of sclerosing cholangiocarcinoma was often made when a focal stenotic lesion was visualized by cholangiogram in a jaundiced patient. However, the inaccuracy of this approach was shown in a series of 98 consecutive patients in whom a diagnosis other than sclerosing adenocarcinoma was made at surgery in 31 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/7\">",
"     7",
"    </a>",
"    ]. There were five papillary cholangiocarcinomas, 12 gallbladder carcinomas that invaded the bile duct, five metastatic tumors to the bile duct, and six benign lesions (three granulomas and three cases of idiopathic benign focal stenosis). Although cholangiography is important for visualizing the site and extent of biliary obstruction, other less invasive and equally accurate studies such as MRCP are emerging in clinical practice (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/51/23351?source=see_link\">",
"     \"Magnetic resonance cholangiopancreatography\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    If needed, both ERCP and PTC techniques can be used to obtain diagnostic bile samples or brush cytology (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75950 \" href=\"mobipreview.htm?38/33/39455\">",
"     image 3",
"    </a>",
"    )&nbsp;(see",
"    <a class=\"local\" href=\"#H18\">",
"     'Establishing a preoperative tissue diagnosis'",
"    </a>",
"    below). Sampling of bile by PTC or ERCP alone will result in positive cytology in about 30 percent of cases of cholangiocarcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. The diagnostic yield is increased if the lesion in question is biopsied or brushings are taken from the duct for cytologic examination. Unfortunately, endoscopic brush cytology in patients who have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiographic findings suggestive of malignancy has a limited sensitivity (35 to 69 percent), and the addition of endoscopic biopsy of malignant strictures increases this value only to 43 to 88 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/45-49\">",
"     45-49",
"    </a>",
"    ]. These tests may be useful in the diagnostic evaluation if they are positive, but a negative test cannot rule out malignant disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19816?source=see_link&amp;anchor=H4#H4\">",
"     \"Endoscopic methods for the diagnosis of pancreatobiliary neoplasms\", section on 'Tissue sampling during ERCP'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Combining brush cytology with tumor marker assessment may provide better diagnostic accuracy. In a previously described study, the combination of a positive brush cytology or an abnormal CA 19-9 had a sensitivity and specificity of 88 percent (95% CI 50 to 99 percent) and 97 percent (95% CI 86 to 100 percent), respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/10\">",
"     10",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"local\" href=\"#H4\">",
"     'Tumor markers'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Once instrumentation of the biliary tree has been accomplished, an endoprosthesis can be placed to provide biliary drainage, thus reducing the risk of infection and cholangitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19816?source=see_link\">",
"     \"Endoscopic methods for the diagnosis of pancreatobiliary neoplasms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/33/25114?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy\", section on 'Criteria for resectability'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Endoscopic ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;For distal bile duct lesions, endoscopic ultrasound (EUS) can visualize the local extent of the primary tumor and the status of regional lymph nodes. EUS-guided fine needle biopsy of tumors and enlarged nodes can also be performed. EUS with fine needle aspiration biopsy has a greater sensitivity for detecting malignancy in distal tumors than does ERCP with brushings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/50\">",
"     50",
"    </a>",
"    ]. This technique also avoids contamination of the biliary tree, which can occur with ERCP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19816?source=see_link\">",
"     \"Endoscopic methods for the diagnosis of pancreatobiliary neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One series included 73 patients with either pancreatic carcinoma (n = 54) or cholangiocarcinoma (n = 19), all of whom underwent preoperative EUS, transabdominal ultrasound (TUS), CT and angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/51\">",
"     51",
"    </a>",
"    ]. EUS was significantly more sensitive for the detection of the cancer (96 percent) than TUS (81 percent), CT (86 percent), or angiography (59 percent). For diagnosing portal venous invasion, EUS was more sensitive (95 percent) and accurate (93 percent) than TUS (55 percent and 67 percent), CT (65 percent and 95 percent), and angiography (75 percent and 79 percent), respectively.",
"   </p>",
"   <p>",
"    The role of EUS for imaging and staging proximal bile duct lesions is uncertain; clinical experience is limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H57599735\">",
"    <span class=\"h3\">",
"     Intraductal ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraductal ultrasound (IDUS) can help distinguish benign from malignant strictures based upon bile duct anatomy and unique sonographic imaging characteristics (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80227 \" href=\"mobipreview.htm?43/21/44370\">",
"     image 4",
"    </a>",
"    ). In addition, IDUS can improve the accuracy of local tumor staging of bile duct carcinomas (",
"    <a class=\"graphic graphic_table graphicRef51131 \" href=\"mobipreview.htm?4/11/4285\">",
"     table 2",
"    </a>",
"    ). IDUS detects early lesions, determines the longitudinal tumor extent, and identifies tumor extension into adjacent organs and major blood vessels with a diagnostic accuracy of nearly 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/53-56\">",
"     53-56",
"    </a>",
"    ]. In particular, IDUS can accurately identify tumor invasion into the pancreatic parenchyma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/54,55,57\">",
"     54,55,57",
"    </a>",
"    ], portal vein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/53,55,57,58\">",
"     53,55,57,58",
"    </a>",
"    ], and right hepatic artery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/55-57,59\">",
"     55-57,59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/36/33353?source=see_link&amp;anchor=H5#H5\">",
"     \"Intraductal ultrasound of the pancreaticobiliary ductal system\", section on 'Biliary tract intraductal ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast to EUS, IDUS is often better able to evaluate the proximal biliary system and surrounding structures, such as the right hepatic artery, portal vein, and the hepatoduodenal ligament (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61520 \" href=\"mobipreview.htm?26/3/26674\">",
"     image 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74347 \" href=\"mobipreview.htm?9/59/10160\">",
"     image 6",
"    </a>",
"    ). Examination of more distant tissues is hindered by its limited depth of penetration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/53,54,57,59\">",
"     53,54,57,59",
"    </a>",
"    ]. IDUS may also have limited value in evaluating lymph nodes, and unlike EUS, IDUS cannot be used to perform fine-needle aspiration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     PET scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positron emission tomography (PET scan) permits visualization of cholangiocarcinomas because of the high glucose uptake of bile duct epithelium. PET scans can detect nodular cholangiocarcinomas as small as 1 cm but is less helpful for infiltrating tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. Perhaps more important is the role of PET in identifying occult metastases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/61-64\">",
"     61-64",
"    </a>",
"    ]. In one series, PET led to a change in surgical management in 11 of 36 patients evaluated for cholangiocarcinoma because of detection of unsuspected metastases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another possible role for PET is in screening patients with PSC for the presence of cholangiocarcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. In one small study PET scans were performed in nine patients with PSC, six with PSC and known cholangiocarcinoma, and five controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/65\">",
"     65",
"    </a>",
"    ]. PET scan correctly identified \"hot spots\" in all four patients with cholangiocarcinoma and none in the other groups. However, the possibility of acute cholangitis causing a false-positive study has to be considered in patients with PSC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/62\">",
"     62",
"    </a>",
"    ]. The place of PET scanning in the evaluation of these patients remains unresolved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiography can accurately document vascular encasement or thrombosis of the portal vein and hepatic artery. However, with the advent of multiphasic CT and MRCP, it is rarely necessary before surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Establishing a preoperative tissue diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, a tissue diagnosis can be obtained by a variety of means in patients suspected of having a hilar malignancy but is often difficult to obtain. The necessity of establishing a tissue diagnosis prior to surgery depends upon the clinical situation. It is not critical for planning surgery in patients with characteristic findings of malignant hilar biliary obstruction and may not be necessary for planning palliative therapy, such as biliary drainage, in unresectable cases.",
"   </p>",
"   <p>",
"    Tissue diagnosis is most important in the following circumstances [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/68\">",
"     68",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Strictures of clinically indeterminate origin (eg, in patients with a history of biliary tract surgery, bile duct stones, or PSC)",
"     </li>",
"     <li>",
"      A situation where the physician or patient would be reluctant to proceed with surgery without a tissue diagnosis, or if the patient's or family's acceptance and adjustment to the diagnosis would be facilitated by having a definitive diagnosis",
"     </li>",
"     <li>",
"      Prior to chemotherapy or radiation therapy, particularly if the patient will be enrolling on a therapeutic clinical trial",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Staging laparoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the enhanced diagnostic capability of newer radiologic studies such as MRCP and dynamic CT, unless there is clear evidence of metastatic disease, true resectability can be determined only by operative evaluation. Laparoscopy can identify the majority of patients with unresectable hilar and distal cholangiocarcinoma, thereby reducing the number of unnecessary laparotomies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. However, true resectability can often be determined only after a complete abdominal exploration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/43/40633/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Making a definitive tissue diagnosis of cholangiocarcinoma preoperatively can be difficult. This is an important clinical issue since up to one-third of patients with symptoms and cholangiogram suggestive of a bile duct malignancy will have either benign fibrosing disease or another malignancy with metastases that obstruct the bile ducts.",
"     </li>",
"     <li>",
"      Preoperative evaluation typically includes right upper quadrant ultrasound, dynamic CT scan, MRCP (in centers with technical expertise in this procedure)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ERCP with",
"      <span class=\"nowrap\">",
"       brushing/biopsy.",
"      </span>",
"      Tumor markers such as CA 19-9 can be useful in conjunction with biopsy or brushings to confirm the diagnosis. If a tissue diagnosis cannot be confirmed, ultrasound or CT-guided percutaneous biopsy should be considered. Even after extensive diagnostic work-up, many patients still require surgical exploration to confirm the diagnosis.",
"     </li>",
"     <li>",
"      Although not specific for cholangiocarcinoma, the presence of certain tumor markers in the serum or bile of patients with cholangiocarcinoma may be of diagnostic value. Most of the studies in this area have been geared toward identifying cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC). We typically use a CA 19-9 value &ge;200",
"      <span class=\"nowrap\">",
"       U/mL",
"      </span>",
"      to increase suspicion for a cholangiocarcinoma in patients with PSC, especially in the presence of a dominant hilar stricture. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Tumor markers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When a diagnosis of cholangiocarcinoma is confirmed at biopsy or is considered likely given a patient's clinical, laboratory, and radiologic findings, attention must be paid to the potential resectability of the lesion since surgery is the only means of attaining cure. The radiographic appearance of malignant biliary strictures is helpful in determining the feasibility of operative resection and in planning surgery.",
"      <strong>",
"      </strong>",
"      Modern CT and MRI techniques almost always appropriately characterize portal vein or hepatic arterial involvement. If questions remain regarding vascular invasion, hepatic arteriography and portal venography may be useful. However, angiography is not needed in the majority of patients.",
"     </li>",
"     <li>",
"      Even with the enhanced diagnostic capability of newer radiologic studies such as MRCP and dynamic CT, unless there is clear evidence of metastatic disease, true resectability can often be determined only by operative evaluation.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/1\">",
"      de Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med 1999; 341:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/2\">",
"      Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994; 14:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/3\">",
"      Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/4\">",
"      Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/5\">",
"      Nagorney DM, Donohue JH, Farnell MB, et al. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993; 128:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/6\">",
"      DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/7\">",
"      Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991; 161:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/8\">",
"      Verbeek PC, van Leeuwen DJ, de Wit LT, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/9\">",
"      Nehls O, Gregor M, Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis 2004; 24:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/10\">",
"      Siqueira E, Schoen RE, Silverman W, et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc 2002; 56:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/11\">",
"      Nakeeb A, Lipsett PA, Lillemoe KD, et al. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 1996; 171:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/12\">",
"      Levy C, Lymp J, Angulo P, et al. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci 2005; 50:1734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/13\">",
"      Patel AH, Harnois DM, Klee GG, et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000; 95:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/14\">",
"      Kim HJ, Kim MH, Myung SJ, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999; 94:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/15\">",
"      Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/16\">",
"      Sinakos E, Saenger AK, Keach J, et al. Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma. Clin Gastroenterol Hepatol 2011; 9:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/17\">",
"      Bj&ouml;rnsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999; 19:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/18\">",
"      Alvaro D, Macarri G, Mancino MG, et al. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. Ann Intern Med 2007; 147:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/19\">",
"      Saini S. Imaging of the hepatobiliary tract. N Engl J Med 1997; 336:1889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/20\">",
"      Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/21\">",
"      Sharma MP, Ahuja V. Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective. Trop Gastroenterol 1999; 20:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/22\">",
"      Bloom CM, Langer B, Wilson SR. Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics 1999; 19:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/23\">",
"      Hann LE, Schwartz LH, Panicek DM, et al. Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment. Radiology 1998; 206:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/24\">",
"      Bach AM, Hann LE, Brown KT, et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 1996; 201:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/25\">",
"      Hann LE, Getrajdman GI, Brown KT, et al. Hepatic lobar atrophy: association with ipsilateral portal vein obstruction. AJR Am J Roentgenol 1996; 167:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/26\">",
"      Valls C, Gum&agrave; A, Puig I, et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 2000; 25:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/27\">",
"      Choi SH, Han JK, Lee JM, et al. Differentiating malignant from benign common bile duct stricture with multiphasic helical CT. Radiology 2005; 236:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/28\">",
"      Kim SA, Lee JM, Lee KB, et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology 2011; 260:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/29\">",
"      Feydy A, Vilgrain V, Denys A, et al. Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. AJR Am J Roentgenol 1999; 172:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/30\">",
"      Tillich M, Mischinger HJ, Preisegger KH, et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. AJR Am J Roentgenol 1998; 171:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/31\">",
"      Zhang Y, Uchida M, Abe T, et al. Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 1999; 23:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/32\">",
"      Lee HY, Kim SH, Lee JM, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 2006; 239:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/33\">",
"      Manfredi R, Barbaro B, Masselli G, et al. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 2004; 24:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/34\">",
"      Fulcher AS, Turner MA. HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma. AJR Am J Roentgenol 1997; 169:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/35\">",
"      Schwartz LH, Coakley FV, Sun Y, et al. Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography. AJR Am J Roentgenol 1998; 170:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/36\">",
"      Zidi SH, Prat F, Le Guen O, et al. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut 2000; 46:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/37\">",
"      Lee MG, Park KB, Shin YM, et al. Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography. World J Surg 2003; 27:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/38\">",
"      Park HS, Lee JM, Choi JY, et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol 2008; 190:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/39\">",
"      Yeh TS, Jan YY, Tseng JH, et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol 2000; 95:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/40\">",
"      R&ouml;sch T, Meining A, Fr&uuml;hmorgen S, et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 2002; 55:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/41\">",
"      Freeman ML, Sielaff TD. A modern approach to malignant hilar biliary obstruction. Rev Gastroenterol Disord 2003; 3:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/42\">",
"      Szklaruk J, Tamm E, Charnsangavej C. Preoperative imaging of biliary tract cancers. Surg Oncol Clin N Am 2002; 11:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/43\">",
"      Desa LA, Akosa AB, Lazzara S, et al. Cytodiagnosis in the management of extrahepatic biliary stricture. Gut 1991; 32:1188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/44\">",
"      Mansfield JC, Griffin SM, Wadehra V, Matthewson K. A prospective evaluation of cytology from biliary strictures. Gut 1997; 40:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/45\">",
"      Sugiyama M, Atomi Y, Wada N, et al. Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology. Am J Gastroenterol 1996; 91:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/46\">",
"      Ponchon T, Gagnon P, Berger F, et al. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 1995; 42:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/47\">",
"      Kubota Y, Takaoka M, Tani K, et al. Endoscopic transpapillary biopsy for diagnosis of patients with pancreaticobiliary ductal strictures. Am J Gastroenterol 1993; 88:1700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/48\">",
"      Rabinovitz M, Zajko AB, Hassanein T, et al. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology 1990; 12:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/49\">",
"      Rustgi AK, Kelsey PB, Guelrud M, et al. Malignant tumors of the bile ducts: diagnosis by biopsy during endoscopic cannulation. Gastrointest Endosc 1989; 35:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/50\">",
"      Abu-Hamda EM, Baron TH. Endoscopic management of cholangiocarcinoma. Semin Liver Dis 2004; 24:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/51\">",
"      Sugiyama M, Hagi H, Atomi Y, Saito M. Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography. Abdom Imaging 1997; 22:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/52\">",
"      Fritscher-Ravens A, Broering DC, Knoefel WT, et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol 2004; 99:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/53\">",
"      Tamada K, Ido K, Ueno N, et al. Assessment of portal vein invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1995; 27:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/54\">",
"      Tamada K, Ueno N, Ichiyama M, et al. Assessment of pancreatic parenchymal invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1996; 28:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/55\">",
"      Kuroiwa M, Tsukamoto Y, Naitoh Y, et al. New technique using intraductal ultrasonography for the diagnosis of bile duct cancer. J Ultrasound Med 1994; 13:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/56\">",
"      Tamada K, Ido K, Ueno N, et al. Assessment of the course and variations of the hepatic artery in bile duct cancer by intraductal ultrasonography. Gastrointest Endosc 1996; 44:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/57\">",
"      Tamada K, Ido K, Ueno N, et al. Preoperative staging of extrahepatic bile duct cancer with intraductal ultrasonography. Am J Gastroenterol 1995; 90:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/58\">",
"      Yasuda K, Mukai H, Nakajima M, Kawai K. Clinical application of ultrasonic probes in the biliary and pancreatic duct. Endoscopy 1992; 24 Suppl 1:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/59\">",
"      Tamada K, Ido K, Ueno N, et al. Assessment of hepatic artery invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1995; 27:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/60\">",
"      Delbeke D, Martin WH, Sandler MP, et al. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 1998; 133:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/61\">",
"      Kim YJ, Yun M, Lee WJ, et al. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 2003; 30:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/62\">",
"      Anderson CD, Rice MH, Pinson CW, et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004; 8:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/63\">",
"      Kluge R, Schmidt F, Caca K, et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001; 33:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/64\">",
"      Li J, Kuehl H, Grabellus F, et al. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol 2008; 98:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/65\">",
"      Keiding S, Hansen SB, Rasmussen HH, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998; 28:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/66\">",
"      Berr F, Wiedmann M, M&ouml;ssner J, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1999; 29:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/67\">",
"      Prytz H, Keiding S, Bj&ouml;rnsson E, et al. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology 2006; 44:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/68\">",
"      Pelsang RE, Johlin FC. A percutaneous biopsy technique for patients with suspected biliary or pancreatic cancer without a radiographic mass. Abdom Imaging 1997; 22:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/69\">",
"      Weber SM, DeMatteo RP, Fong Y, et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg 2002; 235:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/70\">",
"      Callery MP, Strasberg SM, Doherty GM, et al. Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy. J Am Coll Surg 1997; 185:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/43/40633/abstract/71\">",
"      Su CH, Tsay SH, Wu CC, et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996; 223:384.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2500 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-210.101.131.232-8A237B75EA-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40633=[""].join("\n");
var outline_f39_43_40633=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H111257965\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Tumor markers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - CEA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - CA 19-9",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Combined CEA and CA 19-9",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Biliary insulin-like growth factor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Fluorescence in situ hybridization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Radiographic evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - CT scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - MRCP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Cholangiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Endoscopic ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H57599735\">",
"      - Intraductal ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - PET scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Establishing a preoperative tissue diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Staging laparoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2500\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2500|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?9/47/9968\" title=\"diagnostic image 1\">",
"      Cholangiocarcinoma MRCP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?13/6/13423\" title=\"diagnostic image 2\">",
"      Proximal cholangiocarcinoma MRCP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?38/33/39455\" title=\"diagnostic image 3\">",
"      Cholangiocarcinoma ERCP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?43/21/44370\" title=\"diagnostic image 4\">",
"      IDUS distal CBD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?26/3/26674\" title=\"diagnostic image 5\">",
"      IDUS showing CBD PD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?9/59/10160\" title=\"diagnostic image 6\">",
"      IDUS showing CHD PV HA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2500|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/12/19651\" title=\"figure 1\">",
"      Anatomic classification biliary cancers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/36/582\" title=\"figure 2\">",
"      Bismuth-Corlette classification of biliary tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2500|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/11/3259\" title=\"table 1\">",
"      Cond assoc increased CA 19-9",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/11/4285\" title=\"table 2\">",
"      TNM perihilar cholangio",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/52/43848?source=related_link\">",
"      Ampullary carcinoma: Epidemiology, clinical manifestations, diagnosis and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/10/34986?source=related_link\">",
"      Clinical features and diagnosis of primary hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/63/22521?source=related_link\">",
"      Clinical manifestations and diagnosis of primary sclerosing cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41610?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/32/18950?source=related_link\">",
"      Computed tomography of the hepatobiliary tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19816?source=related_link\">",
"      Endoscopic methods for the diagnosis of pancreatobiliary neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/57/19353?source=related_link\">",
"      Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5&rsquo;-nucleotidase, gamma-glutamyl transpeptidase)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43881?source=related_link\">",
"      Epidemiology, pathogenesis, and classification of cholangiocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/46/15082?source=related_link\">",
"      Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22823?source=related_link\">",
"      Glossary of common biostatistical and epidemiological terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/36/33353?source=related_link\">",
"      Intraductal ultrasound of the pancreaticobiliary ductal system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/51/23351?source=related_link\">",
"      Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/39/37491?source=related_link\">",
"      Percutaneous transhepatic cholangiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/33/25114?source=related_link\">",
"      Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/58/34728?source=related_link\">",
"      Treatment options for locally advanced cholangiocarcinoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_43_40634="Interstitial pulmonary edema PA";
var content_f39_43_40634=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53728%7ECARD%2F61783%7ECARD%2F72562%7ECARD%2F75936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53728%7ECARD%2F61783%7ECARD%2F72562%7ECARD%2F75936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary edema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This plain frontal chest radiograph of a 55-year-old male with known coronary artery disease demonstrates characteristic radiographic features of heart failure with interstitial pulmonary edema, bilateral perihilar alveolar edema producing a characteristic butterfly pattern and bilateral pleural effusions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Heart failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 315px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This chest radiograph of a 65-year-old male with dyspnea and orthopnea demonstrates mild pulmonary vascular congestion, septal lymphatic distention (white arrow), interstitial veiling, and enlarged hilar shadows (black arrow), indicative of left ventricular decompensation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Severe heart failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This chest radiography shows severe heart failure with cardiomegaly, pulmonary vascular congestion with infiltrates in the mid lung fields (white arrow), and a small pleural effusion (black arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute left ventricular failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 302px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This plain frontal radiograph of the chest of a 30-year-old male demonstrates bilateral perihilar alveolar edema, giving a typical butterfly appearance, with bilateral interstitial edema and pulmonary venous redistribution to the upper lobes. The acute nature of this condition is manifest by the absence of pleural effusions or an enlarged cardiac silhouette.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40634=[""].join("\n");
var outline_f39_43_40634=null;
var title_f39_43_40635="Differential diagnosis of vulvar pain";
var content_f39_43_40635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F77461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F77461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of vulvar pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Vulvovaginitis (eg, candidal infection, desquamative inflammatory vaginitis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sexually transmitted infections (eg, genital herpes)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vulvovaginal lesions (eg, ulcers, erosions, fissures, papules, pustules)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dermatitis, dermatosis (eg, eczema, psoriasis, lichen sclerosus, lichen planus, lichen simplex chronicus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allergic reaction (eg, seminal plasma allergy, drug reaction)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vulvar or vaginal intraepithelial neoplasia or cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vaginal atrophy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vaginismus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurologic causes (eg, referred pain from injury to the pelvic floor, pudendal nerve injury)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vulvodynia (generalized or localized, provoked or unprovoked)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disorders of the pelvic floor muscles associated with dysfunctional voiding, chronic constipation, musculoskeletal inflammation of pelvic girdle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Female genital mutilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interstitial cystitis/painful bladder syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vulvovaginal manifestations of systemic disease (eg, Crohn's disease, Sj&ouml;gren's syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psychosexual issues (anxiety precluding genital or sexual touch, unresolved genital trauma or sexual abuse)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sexual partner issues (inadequate sexual technique; unwelcome, unaroused, and unlubricated sexual activity)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cultural and religious beliefs leading to expectation of pain with touch",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40635=[""].join("\n");
var outline_f39_43_40635=null;
var title_f39_43_40636="Osteomyelitis staging";
var content_f39_43_40636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64015&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64015&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cierny-Mader staging system for long bone osteomyelitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       Anatomic type",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       <p>",
"        Stage 1: Medullary osteomyelitis",
"       </p>",
"       <p>",
"        Medullary osteomyelitis denotes infection confined to the intramedullary surfaces of the bone. Hematogenous osteomyelitis and infected intramedullary rods are examples of this anatomic type.",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       <p>",
"        Stage 2: Superficial osteomyelitis",
"       </p>",
"       <p>",
"        Superficial osteomyelitis is a true contiguous focus infection of bone; it occurs when an exposed infected necrotic surface of bone lies at the base of a soft-tissue wound.",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       <p>",
"        Stage 3: Localized osteomyelitis",
"       </p>",
"       <p>",
"        Localized osteomyelitis is usually characterized by a full thickness, cortical sequestration which can be removed surgically without compromising bony stability.",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       <p>",
"        Stage 4: Diffuse osteomyelitis",
"       </p>",
"       <p>",
"        Diffuse osteomyelitis is a through-and-through process that usually requires an intercalary resection of the bone to arrest the disease process. Diffuse osteomyelitis includes those infections with a loss of bony stability either before or after debridement surgery.",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       Physiologic class of host*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       Class A denotes a normal host",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       Class B denotes a host with systemic compromise, local compromise, or both",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       Class C denotes a host for whom the morbidity of treatment is worse than that imposed by the disease itself",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       Factors affecting immune surveillance, metabolism, and local vascularity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Systemic factors",
"      </td>",
"      <td class=\"subtitle2_single\">",
"       Local factors",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Malnutrition",
"      </td>",
"      <td class=\"indent1\">",
"       Chronic lymphedema",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Renal or hepatic failure",
"      </td>",
"      <td class=\"indent1\">",
"       Venous stasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Diabetes mellitus",
"      </td>",
"      <td class=\"indent1\">",
"       Major vessel compromise",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Chronic hypoxia",
"      </td>",
"      <td class=\"indent1\">",
"       Arteritis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Immune disease",
"      </td>",
"      <td class=\"indent1\">",
"       Small vessel disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Malignancy",
"      </td>",
"      <td class=\"indent1\">",
"       Extensive scarring",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Extremes of age",
"      </td>",
"      <td class=\"indent1\">",
"       Radiation fibrosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Immunosuppression or immune deficiency",
"      </td>",
"      <td class=\"indent1\">",
"       Neuropathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"indent1\">",
"       Tobacco abuse (&ge;2 packs per day)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Host factors are important for prognosticating containment of infection. A systemically and/or locally compromised host cannot isolate an infectious focus as well as a normal host, so treatment of osteomyelitis is more difficult in such patients.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Cierny, G, Mader, JT, Pennick, H, Contemp Orthop 1985; 10:17.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40636=[""].join("\n");
var outline_f39_43_40636=null;
var title_f39_43_40637="SLED nursing responsibilities";
var content_f39_43_40637=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F69967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F69967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Table of nursing responsibilities for SLED at UCD, UAMS, BIMC and MSHH",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"20%\">",
"     </colgroup>",
"     <colgroup span=\"10\" width=\"8%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        UCD",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        UAMS",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        UCD",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        MHZN/ARMC",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        UPI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        HD nurse",
"       </td>",
"       <td class=\"subtitle2\">",
"        ICU nurse",
"       </td>",
"       <td class=\"subtitle2\">",
"        HD nurse",
"       </td>",
"       <td class=\"subtitle2\">",
"        HD nurse",
"       </td>",
"       <td class=\"subtitle2\">",
"        ICU nurse",
"       </td>",
"       <td class=\"subtitle2\">",
"        ICU nurse",
"       </td>",
"       <td class=\"subtitle2\">",
"        HD nurse",
"       </td>",
"       <td class=\"subtitle2\">",
"        ICU nurse",
"       </td>",
"       <td class=\"subtitle2\">",
"        HD nurse",
"       </td>",
"       <td class=\"subtitle2\">",
"        ICU nurse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hybrid setup",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hybrid initiation",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inservice ICU",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Access care",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Troubleshooting",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extracorporeal circuit or hemodialyzer change",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Routine discontinuation",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Emergency discontinuation",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clearance",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blood draws",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hourly monitoring",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anticoagulation monitoring",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        N/R",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &ndash;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40637=[""].join("\n");
var outline_f39_43_40637=null;
var title_f39_43_40638="Morgan lens flow";
var content_f39_43_40638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Morgan&reg; lens flow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 185px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prolonged irrigation is often necessary for alkali burns. Immediate ophthalmologic consultation is mandatory for all significant eye exposures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: MorTan, Inc. Copyright &copy; 2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40638=[""].join("\n");
var outline_f39_43_40638=null;
var title_f39_43_40639="Heterophyiasis adult worm";
var content_f39_43_40639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Heterophyiasis adult worm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 435px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Adult of",
"    <em>",
"     H. heterophyes",
"    </em>",
"    . In this figure, the following structures are labeled: oral sucker (OS), pharynx (PH), intestine (IN), ventral sucker, or acetabulum (AC), and eggs within the uterus (UT).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Heterophyiasis. Available at:",
"     <a href=\"file://dpd.cdc.gov/dpdx/html/Heterophyiasis.htm\" target=\"_blank\">",
"      file://dpd.cdc.gov/dpdx/html/Heterophyiasis.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_43_40639=[""].join("\n");
var outline_f39_43_40639=null;
